Exhibit 10.1
** **
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS (i) NOT MATERIAL AND (ii) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. REDACTED INFORMATION IS MARKED WITH A [***].
STOCK PURCHASE AGREEMENT
** **
This STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 18, 2026, by and among PMA Graphene Technology Group Inc. (formerly known as Ming Shing Group Holdings Limited), an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Buyer”); those Sellers set forth in Annex I hereto (the “Sellers” and each a “Seller”); and Lanchuang Technology Limited, a BVI business company incorporated under the laws of the British Virgin Islands on July 2, 2026 with registration number 2212775 (the “Company”). Buyer, the Sellers and the Company are referred to collectively herein as the “Parties” and individually as a “Party.”
RECITALS
WHEREAS, the Sellers are the registered and beneficial owners of an aggregate of 50,000 ordinary shares of the Company, par value US$1.00 per share (the “Shares”), in the proportions set forth opposite their names in Annex I constituting, in aggregate, a 100% equity interest in the Company;
WHEREAS, Buyer desires to purchase from the Sellers, and the Sellers desire to sell to Buyer, all of the Shares, upon the terms and subject to the conditions set forth herein, so that, immediately following the Closing, Buyer shall own 100% of the issued and outstanding equity interests in the Company;
WHEREAS, the aggregate consideration payable by Buyer to the Sellers for the Shares will consist of (i) the issuance of Class A Ordinary Shares to the Sellers at the Closing in the aggregate amount of the Share Consideration, and (ii) unsecured convertible promissory notes (the “Notes”) to be issued pursuant to the Note Purchase Agreement in the principal amounts set forth in Annex I hereto, and the Parties intend that the Notes and the Consideration Shares will constitute restricted securities issued in a transaction exempt from registration pursuant to Regulation S under the Securities Act; and
WHEREAS, the Parties desire to set forth herein the terms and conditions governing the purchase and sale of the Shares and the related transactions contemplated hereby.
** **
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants, agreements, representations and warranties set forth herein, and intending to be legally bound hereby, the Parties agree as follows:
ARTICLE I
DEFINITIONS
Section 1.1 Defined Terms. For purposes of this Agreement, the following terms shall have the meanings set forth below:
“Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by or is under common control with such Person.
“Agreement” has the meaning set forth in the preamble.
“Basket” means $1,000,000.
“Beneficial Ownership Limitation” has the meaning given to it in the Note Purchase Agreement.
“Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law to be closed.
“Buyer Indemnified Parties” means Buyer and its Affiliates and their respective directors, officers, employees, managers, agents, successors and permitted assigns.
“Buyer Material Adverse Effect” means any event, change, effect, development, circumstance or occurrence that, individually or in the aggregate, materially impairs Buyer’s ability to consummate the transactions contemplated by this Agreement, the Note Purchase Agreement or the Notes.
“Class A Ordinary Shares” means the Class A ordinary shares, par value US$0.0005 per share, of Buyer, listed on Nasdaq under the trading symbol “PMA.”
“Claim Notice” means written notice of an indemnification claim delivered in accordance with Article VII.
“Closing” means the consummation of the purchase and sale of the Shares and the other transactions contemplated by this Agreement.
“Closing Date” means December 15, 2026, or such other date as Buyer and the Sellers may agree in writing, on which the Closing occurs.
“Company Material Adverse Effect” means any event, change, effect, development, circumstance or occurrence that, individually or in the aggregate, is materially adverse to the business, assets, liabilities, condition (financial or otherwise), operations or results of operations of the Company and its Subsidiaries, taken as a whole, other than any event, change, effect, development, circumstance or occurrence arising out of or resulting from general economic conditions, general industry conditions, changes in law, changes in applicable accounting standards, changes in financial markets or geopolitical conditions, except, in each case, to the extent the Company and its Subsidiaries are disproportionately adversely affected thereby relative to other similarly situated companies operating in the same industries.
“Consideration Shares” means the Class A Ordinary Shares to be issued to the Sellers at the Closing in satisfaction of the Share Consideration.
“Conversion Price” has the meaning given to it in the Notes.
“Conversion Shares” means the Class A Ordinary Shares issuable upon conversion of the Notes.
“Disclosure Schedule” means the disclosure schedule delivered by the Sellers and the Company to Buyer concurrently with the execution of this Agreement.
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Financial Forecast” means the written financial forecast prepared by or on behalf of the Company and delivered to Buyer for the Performance Years, together with its supporting assumptions, as attached to the Note Purchase Agreement.
“Fundamental Representations” means the representations and warranties set forth in Section 3.1, Section 3.2, Section 3.3, Section 3.4, Section 3.5, Section 4.1, Section 4.2, Section 4.3, Section 4.7 and Section 4.8.
“Governmental Authority” means any federal, state, provincial, local, municipal, foreign or supranational government, any governmental, regulatory or administrative authority, agency, commission, department, board, bureau, court, tribunal or instrumentality, and any self-regulatory organization, including Nasdaq and the SEC.
“Indemnified Party” means a Person entitled to indemnification under Article VII.
“Indemnifying Party” means a Party required to provide indemnification under Article VII.
“Intellectual Property” means all intellectual property rights of any kind, whether registered or unregistered and in any jurisdiction, including trademarks, service marks, trade names, domain names and associated goodwill; patents and patent applications; copyrights and works of authorship; trade secrets, know-how, inventions, processes, technical data and confidential information; software; and moral rights, database rights and other proprietary rights.
“Issue Date” means the Closing Date.
“Knowledge” means the actual knowledge of the executive officers and directors of the relevant Person, together with any knowledge that any such Person would have obtained after reasonable inquiry of the relevant books and records and of the officers, employees, outside counsel, auditors and other representatives having responsibility for the subject matter at issue.
“Lien” means any mortgage, pledge, lien, charge, security interest, encumbrance, option, right of first refusal, voting trust, proxy, adverse claim or restriction of any kind.
“Losses” means any and all losses, damages, liabilities, deficiencies, judgments, settlements, awards, fines, penalties, costs and expenses, including reasonable and documented attorneys’ fees and expenses; provided, however, that Losses shall not include punitive damages except to the extent actually awarded to a third party.
“Material Contract” means (i) with respect to Buyer, any contract that Buyer has filed, or is required to file, with the SEC as an exhibit to its annual report on Form 20-F or has furnished on Form 6-K; and (ii) with respect to the Company and its Subsidiaries, those contracts set forth on Schedule 3.7.
“Nasdaq” means The Nasdaq Stock Market LLC, including The Nasdaq Capital Market.
“Nasdaq Rules” means the Nasdaq Listing Rules, including Rules 5110(a), 5250(e)(2), 5615(a)(3), 5635 and 5640, and the applicable interpretive materials thereof.
“Notes” means the senior unsecured perpetual zero coupon convertible notes to be issued by Buyer to the Sellers, in substantially the form attached as Exhibit B, and each such note, a “Note.”
“Note Consideration” means the portion of the Purchase Price satisfied by Buyer through the issuance and delivery of the Notes, pursuant to and governed by the Note Purchase Agreement.
“Note Purchase Agreement” means the Convertible Note Purchase Agreement, to be dated as of the Closing Date, by and between Buyer and the Sellers (in their capacity as purchasers thereunder), substantially in the form attached as Exhibit A, pursuant to which Buyer shall issue the Notes.
“Note Recipients” means the Sellers in their capacity as ‘Holder’ under the terms of the Notes and ‘Purchaser’ under the terms of the Note Purchase Agreement, and each a ‘Note Recipient.’
“Outside Date” means March 31, 2027.
“Performance Schedule” means the schedule of Performance Targets, metrics, thresholds and measurement basis for each Performance Year attached as Schedule 1 to the Note Purchase Agreement.
“Performance Target” and “Performance Year” have the meanings given to them in the Note Purchase Agreement.
“Performance Tranche Limitation” has the meaning given to it in the Note Purchase Agreement.
“Permitted Liens” means (a) statutory Liens for Taxes not yet due and payable or being contested in good faith by appropriate proceedings, (b) mechanics’, carriers’, workmen’s, repairmen’s and similar statutory Liens arising in the ordinary course of business for amounts not yet due and payable, and (c) such imperfections of title, easements and encumbrances that do not materially detract from the value of, or materially interfere with the present use of, the assets subject thereto; provided that no Permitted Lien shall attach to the Shares.
“Person” means any individual, corporation, partnership, limited liability company, association, trust, joint venture, unincorporated organization, Governmental Authority or other entity.
“Purchase Price” means the aggregate consideration payable by Buyer for the Shares, equal to the total of the Share Consideration and the Note Consideration.
“Related Party” means any Seller, any director, officer or shareholder of the Company or any of its Subsidiaries, any immediate family member of any such natural person, and any Affiliate of any of the foregoing Persons (other than the Company and its Subsidiaries).
“Sanctions” means any applicable economic or financial sanctions, trade embargoes or restrictive measures administered, enacted or enforced by the United States government (including the Office of Foreign Assets Control of the U.S. Department of the Treasury), the United Nations Security Council, the European Union, His Majesty’s Treasury of the United Kingdom or any other applicable Governmental Authority, and “Sanctioned Person” means any Person that is the subject or target of Sanctions.
“SEC” means the U.S. Securities and Exchange Commission.
“SEC Reports” means Buyer’s annual reports on Form 20-F, current reports on Form 6-K and any registration statements, prospectuses or other reports or documents filed with or furnished to the SEC under the Securities Act or the Exchange Act since January 1, 2026.
“Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, and “Regulation S” and “Rule 144” mean the respective rules promulgated thereunder.
“Seller Indemnified Parties” means the Sellers and their respective Affiliates and their respective directors, officers, employees, managers, agents, successors and permitted assigns.
“Share Consideration” means US$81,250,000 in aggregate value of Class A Ordinary Shares, to be issued directly to the Sellers at the Closing in the proportions set forth in Annex I, the aggregate number of which shall equal US$81,250,000 divided by the Share Issue Price.
“Share Issue Price” means US$1.30 per Class A Ordinary Share.
“Subsidiary” means, with respect to any Person, any entity of which such Person directly or indirectly owns securities or other interests representing more than 50% of the voting power or economic interests.
“Tax” or “Taxes” means any and all federal, state, local, foreign and other taxes, charges, fees, levies, imposts, duties and other assessments of any kind, together with any interest, penalties and additions thereto.
“Transaction Documents” means this Agreement, the Note Purchase Agreement, the Notes, the share transfer instruments, the officer’s certificates and all other agreements, certificates, instruments and documents executed and delivered in connection with the transactions contemplated hereby.
Section 1.2 Interpretation. Unless the context otherwise requires, (a) words in the singular include the plural and vice versa; (b) references to Articles, Sections, Exhibits, Annexes and Schedules are to those of this Agreement; (c) the words “include,” “includes” and “including” shall be deemed to be followed by the words “without limitation”; (d) references to “dollars,” “US$” or “$” are to United States dollars; and (e) the word “or” is not exclusive.
ARTICLE II
PURCHASE AND SALE; PURCHASE PRICE; CLOSING
Section 2.1 Purchase and Sale of the Shares. Upon the terms and subject to the conditions of this Agreement, at the Closing, each Seller shall sell, transfer, assign and deliver to Buyer, and Buyer shall purchase and accept from each Seller, all right, title and interest in and to the Shares set forth opposite such Seller’s name in Annex I, free and clear of all Liens, such that Buyer acquires 100% of the issued and outstanding equity interests in the Company at the Closing.
Section 2.2 Purchase Price. The aggregate Purchase Price for the Shares shall be an amount equal to the sum of the Share Consideration and the Note Consideration, allocated among the Sellers in the proportions set forth in Annex I. The parties agree that the Share Issue Price is a contractual reference agreed between the parties hereto, and shall not be construed as a representation or warranty by either Party as to the fair value or fair market value of the Class A Ordinary Shares for financial reporting, valuation, taxation, or any other purpose not expressly contemplated herein.
Section 2.3 Consideration Shares. At the Closing, Buyer shall issue and allot to each Seller, credited as fully paid, the number of Consideration Shares set forth opposite such Seller’s name in Annex I, being such Seller’s portion of the Share Consideration divided by the Share Issue Price, rounded down to the nearest whole share, with no cash payment in lieu of any fractional entitlement. The Consideration Shares shall rank pari passu in all respects with the existing Class A Ordinary Shares from the date of issue and shall not be subject to the Performance Tranche Limitations or the Beneficial Ownership Limitation.
Section 2.4 Notes. At the Closing, Buyer shall execute and deliver to each Seller, pursuant to and subject to the Note Purchase Agreement, a Note in the original principal amount set forth opposite such Seller’s name in Annex I. The Notes are governed exclusively by the Note Purchase Agreement and the Notes and are issued solely as partial consideration for the Shares and not as a fundraising instrument. Except as expressly provided in the Note Purchase Agreement or the Notes, this Agreement does not amend or supplement the terms of the Notes.
Section 2.5 The Closing. The Closing shall take place remotely by electronic exchange of signatures and closing deliverables, concurrently with the closing under the Note Purchase Agreement, at 10:00 a.m. New York time on the Closing Date, or at such other time and place as Buyer and the Sellers may agree in writing. All transactions to occur at the Closing shall be deemed to occur simultaneously, and none shall be deemed completed until all have been completed. The Consideration Shares and the Notes shall be issued contemporaneously with the transfer of valid title to all of the Shares to Buyer.
Section 2.6 Sellers’ Closing Deliverables. At or prior to the Closing, the Sellers and the Company shall deliver, or cause to be delivered, to Buyer:
| a. | share certificates (if any) representing the Shares, together with duly executed instruments of transfer in favor of Buyer, and evidence that Buyer has been entered in the register of members of the Company as the holder of all of the Shares, including a certified copy of the updated register of members; | |
| b. | the resignations of such directors and officers of the Company and its Subsidiaries as Buyer may request, and board resolutions of the Company approving the transfer of the Shares and the registration of Buyer; | |
| c. | certified copies of the resolutions of the board of directors (and, if required, the shareholders) of each Seller and the Company authorizing the Transaction Documents to which it is a party; | |
| d. | a certificate of good standing for the Company and each Seller and an updated certificate of incumbency of the Company, each dated not more than five Business Days before the Closing Date; | |
| e. | a certificate executed by an authorized officer of each Seller and the Company certifying that the conditions set forth in Section 6.2(a), (b) and (c) have been satisfied; | |
| f. | the Note Purchase Agreement duly executed by each Seller; | |
| g. | documentation evidencing each Seller’s jurisdiction of incorporation, registered number, ultimate beneficial ownership, authority and capacity, and all know-your-customer information reasonably requested by Buyer or its transfer agent; and | |
| h. | such other documents, instruments and writings as Buyer may reasonably request to consummate the transactions contemplated hereby. |
Section 2.7 Buyer’s Closing Deliverables. At or prior to the Closing, Buyer shall deliver, or cause to be delivered, to each Seller:
| a. | evidence of the issuance of the Consideration Shares to each Seller, including book-entry statements from Buyer’s transfer agent or share certificates and an updated register of members; | |
| b. | the Note Purchase Agreement and each Note, duly executed by Buyer; | |
| c. | certified copies of the resolutions of the board of directors of Buyer approving the Transaction Documents, the issuance of the Consideration Shares and the Notes and the reservation of the Conversion Shares, and a certificate of good standing for Buyer; | |
| d. | a certificate executed by an authorized officer of Buyer certifying that the conditions set forth in Section 6.3(a) and (b) have been satisfied; and | |
| e. | such other documents, instruments and writings as the Sellers may reasonably request to consummate the transactions contemplated hereby. |
Section 2.8 Securities Law Exemptions; Legends. The Consideration Shares, the Notes and the Conversion Shares have not been registered under the Securities Act or any state securities laws and are being issued in reliance on Regulation S. The Consideration Shares, the Notes and any Conversion Shares shall bear customary restrictive legends and be subject to stop-transfer instructions. No unrestricted resale status is assured, and Buyer makes no commitment to register any such securities.
Section 2.9 Withholding. Buyer shall be entitled to deduct and withhold from any consideration deliverable under this Agreement any amount required to be deducted or withheld under applicable law; provided that Buyer gives reasonable prior notice to the relevant Seller and cooperates in good faith to minimize such withholding where legally permissible.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE SELLERS AND THE COMPANY
Except as set forth in the Disclosure Schedule, each Seller (severally and not jointly as to the representations and warranties relating to such Seller itself, its Shares and its Note, and jointly and severally as to all other representations and warranties in this Article III and in its capacity as a Note Recipient where so indicated), and, where expressly stated, the Company represent and warrant to Buyer as of the date hereof and as of the Closing Date as follows:
Section 3.1 Organization; Authority. Such Seller is duly incorporated, validly existing and in good standing under the laws of its jurisdiction of incorporation and has all requisite power, authority and capacity to execute, deliver and perform this Agreement and the other Transaction Documents to which it is a party. The Company is a BVI business company duly incorporated on July 2, 2026 with registration number 2212775, validly existing and in good standing under the laws of the British Virgin Islands, and has all requisite power and authority to own its assets and carry on its business as presently conducted.
Section 3.2 Authorization; Enforceability. The execution, delivery and performance by such Seller and the Company of the Transaction Documents to which it is a party have been duly authorized by all necessary corporate or other action. This Agreement has been duly executed and delivered by such Seller and the Company and constitutes a valid and binding obligation of each, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors’ rights generally and to general principles of equity.
Section 3.3 Title to Shares. Such Seller is the sole registered and beneficial owner of the Shares set forth opposite its name in Annex I, free and clear of all Liens other than restrictions under applicable securities laws and the memorandum and articles of association of the Company, and has the full right to transfer such Shares to Buyer. Upon registration of Buyer in the register of members of the Company at the Closing, Buyer shall acquire good and valid legal and beneficial title to such Shares, free and clear of all Liens.
Section 3.4 Capitalization. The Shares constitute all of the issued and outstanding shares and equity interests of the Company on a fully diluted and as-converted basis. The capitalization of the Company is accurately set forth in Annex I. All of the Shares have been duly authorized and validly issued, are fully paid and were issued in compliance with applicable law and the memorandum and articles of association of the Company. Except as set forth on Schedule 3.4, there are no outstanding options, warrants, convertible securities, subscriptions, preemptive rights or other rights or commitments obligating the Company or any of its Subsidiaries to issue, transfer, sell, redeem or repurchase any equity interests.
Section 3.5 Subsidiaries. Schedule 3.5 sets forth a true and complete list of each Subsidiary of the Company, its jurisdiction of organization, its issued share capital and the holders thereof. The Company owns, directly or indirectly, all of the equity interests of each Subsidiary free and clear of all Liens. The Company and its Subsidiaries own or have valid rights to all businesses and assets necessary to conduct the business contemplated to be acquired by Buyer, as described in Schedule 3.5.
Section 3.6 No Conflicts; Consents. The execution, delivery and performance by such Seller and the Company of the Transaction Documents to which it is a party do not and will not (a) violate the organizational documents of such Seller, the Company or any Subsidiary, (b) violate any applicable law or order, (c) result in a breach of, or default or right of termination or acceleration under, any Material Contract, or (d) require any consent, approval or filing with any Governmental Authority or other Person, except, in the case of clauses (b) through (d), as would not reasonably be expected to have a Company Material Adverse Effect.
Section 3.7 Material Contracts. Schedule 3.7 sets forth a true and complete list of each contract to which the Company or any Subsidiary is a party that is material to its business. Each Material Contract is in full force and effect and is a valid and binding obligation of the Company or such Subsidiary and, to the Knowledge of the Company, each counterparty. Neither the Company nor any Subsidiary nor, to the Knowledge of the Company, any counterparty is in material breach of any Material Contract, and no written notice of termination or material dispute has been received.
Section 3.8 Financial Statements; No Undisclosed Liabilities. True and complete copies of the consolidated financial statements of the Company and its Subsidiaries for the period(s) ended October 31, 2026 (the “Financial Statements”) have been delivered to Buyer. The Financial Statements fairly present in all material respects the financial condition and results of operations of the relevant entities as of the dates and for the periods indicated, in accordance with U.S. GAAP consistently applied. Neither the Company nor any Subsidiary has any liability of any nature, except (a) as reflected in the Financial Statements, (b) liabilities incurred in the ordinary course of business since the date thereof, none of which is material, or (c) liabilities arising under this Agreement.
Section 3.9 Financial Forecast. The Financial Forecast and the supporting assumptions for the Performance Schedule have been prepared in good faith on the basis of assumptions believed by the Sellers and the Company to be reasonable when prepared, and all material assumptions, limitations and dependencies relevant thereto have been fairly disclosed to Buyer. The Performance Targets are separately and expressly stated in the Performance Schedule.
Section 3.10 Compliance with Laws; Permits. The Company and each Subsidiary is, and during the past five years has been, in compliance in all material respects with all applicable laws, and holds all material permits, licenses and authorizations necessary for the conduct of its business as presently conducted, each of which is in full force and effect.
Section 3.11 Litigation. There is no action, suit, proceeding, claim, investigation or inquiry pending or, to the Knowledge of the Company, threatened in writing against the Company, any Subsidiary or any Seller that would reasonably be expected to have a Company Material Adverse Effect or to prevent or materially delay the Closing, and there are no outstanding orders of any Governmental Authority binding on the Company or any Subsidiary.
Section 3.12 Taxes. The Company and each Subsidiary has timely filed all material Tax returns required to be filed by it, all of which are true, correct and complete in all material respects, and has timely paid all material Taxes due. There are no material Tax audits or proceedings pending or, to the Knowledge of the Company, threatened, and there are no Liens for Taxes on the assets of the Company or any Subsidiary other than Permitted Liens.
Section 3.13 Intellectual Property. The Company and its Subsidiaries own or have valid rights to use all Intellectual Property necessary in all material respects for the conduct of their business. To the Knowledge of the Company, the conduct of such business does not infringe, misappropriate or violate the Intellectual Property of any third Person, no written claim alleging the same is pending or threatened, and no third Person is infringing any material Intellectual Property owned by the Company or any Subsidiary. All material Intellectual Property developed by employees or contractors has been validly assigned to the Company or a Subsidiary.
Section 3.14 Employment Matters. The Company and each Subsidiary is in compliance in all material respects with all applicable labor, employment, social insurance, immigration, wage and hour and occupational safety laws, and there are no pending or, to the Knowledge of the Company, threatened material labor disputes.
Section 3.15 Real Property; Assets. Neither the Company nor any Subsidiary owns any real property. Schedule 3.15 lists all real property leased by the Company or any Subsidiary. The Company and its Subsidiaries have good title to, or valid leasehold or license interests in, all material tangible assets used in their business, free and clear of all Liens other than Permitted Liens.
Section 3.16 Related Party Transactions. Neither the Company nor any Subsidiary is a party to any contract or arrangement with any Related Party, other than ordinary course employment arrangements disclosed to Buyer, and no Related Party owns any material asset used in, or has any material claim against, the business of the Company or any Subsidiary.
Section 3.17 Sanctions. None of the Company, any Subsidiary, any Seller or, to the Knowledge of the Company, any of their respective directors, officers, employees or agents is a Sanctioned Person or, during the past five years, has engaged in any dealing with or for the benefit of any Sanctioned Person or otherwise violated Sanctions in any material respect.
Section 3.18 Anti-Money Laundering; Anti-Corruption. The Company, its Subsidiaries and each Seller have complied in all material respects with all applicable anti-money laundering, counter-terrorist financing and anti-corruption laws. None of them nor, to the Knowledge of the Company, any Person acting on their behalf has, during the past five years, directly or indirectly made, offered, promised, authorized or received any unlawful payment, bribe, kickback or other thing of value in violation of any such law.
Section 3.19 Brokers. No broker, finder or investment banker is entitled to any fee or commission in connection with the transactions contemplated hereby based on arrangements made by or on behalf of any Seller or the Company, other than fees that will be paid solely by the Sellers.
Section 3.20 Investment Representations. Such Seller (a) is acquiring the Consideration Shares, its Note and any Conversion Shares for its own account for investment and not with a view to any distribution in violation of the Securities Act; (b) has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of such investment and is able to bear the economic risk thereof, including the complete loss of its investment; (c) has had the opportunity to ask questions of and receive answers from Buyer and has reviewed the SEC Reports; and (d) understands that such securities are “restricted securities” that may not be transferred except pursuant to registration or an available exemption.
Section 3.21 Regulation S. Such Seller is not a “U.S. person” (as defined in Regulation S), is outside the United States at the time of execution of this Agreement, is not acquiring such securities for the account or benefit of any U.S. person, and will not offer or sell such securities within the United States or to a U.S. person during the one-year distribution compliance period commencing on the Closing Date except pursuant to registration or an available exemption. Neither such Seller nor any of its Affiliates has entered or will enter into any hedging, short sale or similar transaction in respect of such securities except in compliance with the Securities Act.
Section 3.22 Beneficial Ownership Disclosure. Such Seller has disclosed to Buyer in writing its ultimate beneficial owner(s) and all Persons whose beneficial ownership of Class A Ordinary Shares would be aggregated with such Seller under Section 13(d) of the Exchange Act, and is not a member of a “group” with any other Person with respect to the securities of Buyer except as so disclosed.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF BUYER
Except as disclosed in the SEC Reports, Buyer represents and warrants to the Sellers as of the date hereof and as of the Closing Date as follows:
Section 4.1 Organization; Good Standing. Buyer is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands and has all requisite corporate power and authority to own its assets and carry on its business as presently conducted.
Section 4.2 Authorization; Enforceability. Buyer has all requisite corporate power and authority to enter into and perform the Transaction Documents. All corporate action necessary for the authorization, execution, delivery and performance of the Transaction Documents, the issuance of the Consideration Shares and the Notes, and the reservation and issuance of the Conversion Shares has been taken. Each Transaction Document to which Buyer is a party has been duly executed and delivered and constitutes a valid and binding obligation of Buyer, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws and general principles of equity.
Section 4.3 Valid Issuance. The Consideration Shares, when issued at the Closing, and the Conversion Shares, when issued upon conversion of the Notes in accordance with their terms, will be duly authorized, validly issued, fully paid and non-assessable, free of preemptive rights and Liens (other than restrictions under applicable securities laws). The Notes, when issued, will constitute valid and binding obligations of Buyer.
Section 4.4 No Conflicts; Consents. The execution, delivery and performance by Buyer of the Transaction Documents do not and will not (a) conflict with Buyer’s memorandum and articles of association, (b) violate any applicable law, (c) result in a material breach of any Material Contract of Buyer, save as disclosed or waived, except in the case of clauses (b) and (c) as would not reasonably be expected to have a Buyer Material Adverse Effect. No consent of or filing with any Governmental Authority is required, except for Nasdaq notifications and approvals contemplated by Section 5.5, filings with the SEC and such consents the failure of which to obtain would not reasonably be expected to have a Buyer Material Adverse Effect.
Section 4.5 SEC Reports; Financial Statements. Since January 1, 2026, Buyer has filed or furnished all reports required to be filed or furnished by it as a foreign private issuer under the Exchange Act and the Securities Act. As of their respective dates, the SEC Reports complied in all material respects with applicable requirements and did not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein not misleading. The financial statements included in the SEC Reports fairly present in all material respects the consolidated financial condition and results of operations of Buyer as of the dates and for the periods indicated.
Section 4.6 Securities Law and Listing Compliance. Buyer is in compliance in all material respects with applicable securities laws and the Nasdaq Rules. The Class A Ordinary Shares are registered under Section 12 of the Exchange Act and listed on Nasdaq, and Buyer has received no notice of delisting. Assuming the accuracy of the Sellers’ representations in Sections 3.20 and 3.21, the issuance of the Consideration Shares, the Notes and the Conversion Shares is exempt from registration under the Securities Act.
Section 4.7 Capitalization; Reservation. The authorized share capital of Buyer is as set forth in the SEC Reports. Buyer has, and at the Closing will have, sufficient authorized but unissued Class A Ordinary Shares to issue the Consideration Shares and to reserve sufficient Class A Ordinary Shares for issuance of the Conversion Shares upon conversion of the full outstanding principal amount of the Notes at the Conversion Price, subject to the Beneficial Ownership Limitation, the Performance Tranche Limitations and applicable law.
Section 4.8 Foreign Private Issuer; Home Country Practice; Shareholder Approval. Buyer is a “foreign private issuer” within the meaning of the Exchange Act and, to the extent applicable, is eligible to rely on home country practice under Nasdaq Rule 5615(a)(3). No approval of Buyer’s shareholders is required in connection with the Transaction Documents or the issuance of the Consideration Shares, the Notes or the Conversion Shares under Cayman Islands law, Buyer’s memorandum and articles of association or the Nasdaq Rules (after giving effect to any properly available home country practice exemption).
Section 4.9 No General Solicitation; Brokers. Neither Buyer nor any Person acting on its behalf has engaged in any general solicitation or directed selling efforts in connection with the offer of the Consideration Shares or the Notes. No broker or finder is entitled to any fee in connection with the transactions contemplated hereby based on arrangements made by Buyer, other than fees that will be paid solely by Buyer.
ARTICLE V
COVENANTS
Section 5.1 Conduct of Business. From the date hereof until the Closing or earlier termination of this Agreement, except as expressly contemplated hereby, required by law or consented to in writing by Buyer (such consent not to be unreasonably withheld, conditioned or delayed), the Sellers shall cause the Company and each Subsidiary to conduct its business in the ordinary course consistent with past practice and to use commercially reasonable efforts to preserve intact its business organization and relationships, and shall not permit the Company or any Subsidiary to: (a) amend its organizational documents; (b) issue, sell, pledge, redeem or repurchase any equity interests or securities convertible into equity interests, or declare or pay any dividend or distribution; (c) incur or guarantee any indebtedness for borrowed money outside the ordinary course; (d) make any material acquisition or disposition of assets or businesses; (e) enter into, materially amend or terminate any Material Contract outside the ordinary course; (f) materially increase compensation or adopt any new benefit plan, other than as required by existing contracts; (g) enter into any transaction with a Related Party; (h) change its accounting methods or cash management practices; or (i) take any action that would reasonably be expected to make any representation in Article III untrue in any material respect.
Section 5.2 Access to Information. Until the Closing, the Sellers shall cause the Company to afford Buyer and its representatives reasonable access, upon reasonable notice and during normal business hours, to the books, records, contracts, facilities and personnel of the Company and its Subsidiaries for purposes of legal, financial, tax and business due diligence, subject to applicable law and customary confidentiality protections.
Section 5.3 Efforts; Regulatory Filings. Each Party shall use commercially reasonable efforts to take all actions necessary, proper or advisable under applicable law to consummate the transactions contemplated hereby as promptly as practicable, including obtaining all necessary consents and approvals and making all required filings.
Section 5.4 Confidentiality; Public Announcements. The existence and terms of the transactions contemplated hereby shall be kept confidential, except to the extent disclosure is required by applicable law, SEC rules, the Nasdaq Rules or any Governmental Authority. Any public announcement shall, to the extent practicable, be coordinated between Buyer and the Sellers, subject always to Buyer’s overriding legal and regulatory disclosure obligations.
Section 5.5 Nasdaq and SEC Matters. Buyer shall (a) make all required Nasdaq notifications, listing applications and other filings relating to the Consideration Shares, the Notes and the Conversion Shares, including any Listing of Additional Shares notification under Nasdaq Rule 5250(e)(2) within the required time period; (b) obtain, prior to the Closing, any initial listing approval required under Nasdaq Rule 5110(a); (c) make all filings, disclosures and notifications required in connection with any reliance on home country practice under Nasdaq Rule 5615(a)(3); and (d) to the extent required, furnish a current report on Form 6-K describing the Transaction Documents. The Sellers shall provide all information reasonably requested by Buyer in connection with the foregoing.
Section 5.6 Share Reservation. Buyer shall have sufficient authorized share capital to issue the Consideration Shares at the Closing and, from the Issue Date until the Notes have been fully converted, redeemed or cancelled, shall reserve sufficient authorized but unissued Class A Ordinary Shares to satisfy conversion of the full outstanding principal amount of the Notes at the Conversion Price, subject to the Beneficial Ownership Limitation, the Performance Tranche Limitations and applicable law.
Section 5.7 Financial Forecast; Performance Information. Prior to the Closing, the Sellers shall cause the Company to deliver to Buyer the Financial Forecast, prepared on a basis consistent with the Performance Schedule. Following the Closing, for so long as any performance tranche of the Notes remains outstanding and non-convertible, each Seller shall, to the extent it has the legal right or practical ability to do so, cooperate with Buyer in the provision of the information required under the Note Purchase Agreement.
Section 5.8 Anti-Circumvention. No Seller shall effect any conversion, transfer or other arrangement designed to circumvent the Beneficial Ownership Limitation or the Performance Tranche Limitations, whether through nominees, Affiliates, derivative arrangements or otherwise.
Section 5.9 [Reserved].
Section 5.10 Further Assurances. From time to time after the Closing, each Party shall execute and deliver such additional instruments and take such further actions as may be reasonably necessary to carry out the purposes of this Agreement and to vest in Buyer all right, title and interest in and to the Shares.
ARTICLE VI
CONDITIONS TO CLOSING
Section 6.1 Mutual Conditions. The obligations of each Party to consummate the Closing are subject to the satisfaction or waiver of the following conditions: (a) no injunction, restraint, illegality or order of any Governmental Authority shall be in effect prohibiting the Closing; (b) all Nasdaq, SEC and other regulatory notifications, applications, filings and approvals required before the Closing for the transactions contemplated hereby and the issuance of the Consideration Shares and the Notes shall have been made or obtained, including any initial listing approval required under Nasdaq Rule 5110(a), and arrangements shall be in place for the lawful issuance of the Conversion Shares; (c) any shareholder approval of Buyer required under applicable law, Buyer’s memorandum and articles of association or the Nasdaq Rules (after giving effect to any properly available home country practice exemption) shall have been obtained; and (d) all required internal approvals of the Sellers and the Company shall have been obtained.
Section 6.2 Conditions to Buyer’s Obligations. The obligations of Buyer to consummate the Closing are subject to the satisfaction or waiver by Buyer of the following additional conditions:
| a. | the representations and warranties of the Sellers and the Company shall be true and correct as of the Closing Date (except those made as of a specified date, which shall be true and correct as of such date), except where the failure to be true and correct would not reasonably be expected to have a Company Material Adverse Effect; provided that the Fundamental Representations shall be true and correct in all respects, except for de minimis inaccuracies; | |
| b. | the Sellers and the Company shall have performed in all material respects all covenants required to be performed by them at or prior to the Closing; | |
| c. | no Company Material Adverse Effect shall have occurred and be continuing; | |
| d. | Buyer shall have completed legal, financial, tax and business due diligence on the Company and its Subsidiaries to its reasonable satisfaction; | |
| e. | Buyer shall have received the Financial Forecast in form and substance reasonably satisfactory to it, prepared on a basis consistent with the Performance Schedule; | |
| f. | the board of directors of Buyer shall have approved the transactions contemplated hereby; | |
| g. | Buyer shall have received all documents required to transfer valid title to all of the Shares, such that Buyer acquires 100% of the Company at the Closing; | |
| h. | the Note Purchase Agreement shall have been duly executed by each Seller; | |
| i. | Buyer shall have received each of the deliverables set forth in Section 2.6. |
Section 6.3 Conditions to Sellers’ Obligations. The obligations of the Sellers to consummate the Closing are subject to the satisfaction or waiver by the Sellers of the following additional conditions: (a) the representations and warranties of Buyer shall be true and correct as of the Closing Date, except where the failure to be true and correct would not reasonably be expected to have a Buyer Material Adverse Effect; provided that the Fundamental Representations of Buyer shall be true and correct in all respects, except for de minimis inaccuracies; (b) Buyer shall have performed in all material respects all covenants required to be performed by it at or prior to the Closing; (c) the Note Purchase Agreement and the Notes shall have been duly executed by Buyer; (d) no Buyer Material Adverse Effect shall have occurred and be continuing; and (e) the Sellers shall have received each of the deliverables set forth in Section 2.7.
ARTICLE VII
INDEMNIFICATION
Section 7.1 Survival. The representations and warranties contained in this Agreement shall survive the Closing for a period of three (3) years following the Closing Date; provided, however, that (a) the Fundamental Representations shall survive until the expiration of the applicable statute of limitations plus sixty (60) days, and (b) any covenant or agreement to be performed after the Closing shall survive in accordance with its terms. If a valid Claim Notice is delivered prior to the expiration of the applicable survival period, the applicable representation, warranty or covenant shall survive solely with respect to the matter set forth in such Claim Notice until such claim is finally resolved.
Section 7.2 Indemnification by the Sellers. Subject to the limitations set forth in this Article VII, from and after the Closing, the Sellers shall, jointly and severally (provided however that liability for any breach of a representation or warranty given by a Seller severally as to itself shall be borne severally by the Seller that gave it), indemnify, defend and hold harmless the Buyer Indemnified Parties from and against any and all Losses arising out of or resulting from: (a) any breach of any representation or warranty of the Sellers or the Company contained in this Agreement; (b) any breach of any covenant or agreement of the Sellers or the Company contained in this Agreement; (c) any Taxes of the Company or any of its Subsidiaries for any taxable period ending on or before the Closing Date (or the portion of any straddle period ending on and including the Closing Date); and (d) any action, suit, proceeding or claim against the Company or any of its Subsidiaries to the extent arising out of any act, omission, event or circumstance occurring or existing on or prior to the Closing Date.
Section 7.3 Indemnification by Buyer. Subject to the limitations set forth in this Article VII, from and after the Closing, Buyer shall indemnify, defend and hold harmless the Seller Indemnified Parties from and against any and all Losses arising out of or resulting from: (a) any breach of any representation or warranty of Buyer contained in this Agreement; and (b) any breach of any covenant or agreement of Buyer contained in this Agreement.
Section 7.4 Limitations. Except in the case of fraud, intentional misconduct, breaches of Fundamental Representations or claims under Section 7.2(c) or Section 7.2(d), no Indemnifying Party shall be liable for indemnification under this Article VII unless and until the aggregate amount of Losses incurred by the applicable Indemnified Party exceeds the Basket, in which event the Indemnified Party shall be entitled to recover only Losses in excess of the Basket. Except in the case of fraud, intentional misconduct or breaches of Fundamental Representations, the aggregate liability of the Sellers for indemnification under Section 7.2(a) shall not exceed the Purchase Price. The aggregate liability of Buyer for indemnification under Section 7.3(a) shall not exceed the Purchase Price.
Section 7.5 Claims Procedure. An Indemnified Party seeking indemnification under this Article VII shall deliver a Claim Notice to the Indemnifying Party specifying in reasonable detail the basis for the claim and, if known, the amount of Losses claimed. The failure to provide a Claim Notice promptly shall not relieve the Indemnifying Party of its obligations hereunder except to the extent the Indemnifying Party is materially prejudiced thereby. The Indemnifying Party shall have the right, upon written notice to the Indemnified Party, to assume the defense of any third-party claim with counsel reasonably satisfactory to the Indemnified Party, subject to customary conditions and limitations. The Indemnified Party shall have the right to participate in the defense at its own expense. If the Indemnifying Party does not assume the defense of a third-party claim within thirty (30) days of receipt of a Claim Notice, the Indemnified Party shall be entitled to assume the defense of such claim at the expense of the Indemnifying Party, and the Indemnified Party may consent to the entry of any judgment or enter into any settlement with respect to such claim without the consent of the Indemnifying Party (and the Indemnifying Party shall be bound by any such judgment or settlement).
Section 7.6 Mitigation; Insurance.
(a) Each Indemnified Party shall use commercially reasonable efforts to mitigate any Losses for which it may be entitled to indemnification under this Article VII; provided, however, that the failure to so mitigate shall not limit or reduce the amount of any indemnification to which such Indemnified Party is entitled except to the extent the Indemnifying Party demonstrates that such failure actually increased the Losses incurred.
(b) The amount of any Losses for which indemnification is provided under this Article VII shall be reduced by any insurance proceeds actually received by the Indemnified Party with respect to such Losses (net of any costs of recovery and any increase in premiums resulting from such claim).
(c) If, after an Indemnified Party receives any indemnification payment under this Article VII, such Indemnified Party receives any insurance proceeds or other recovery with respect to the same Losses, the Indemnified Party shall promptly pay to the Indemnifying Party an amount equal to the lesser of (i) the amount of such insurance proceeds or other recovery (net of any costs of recovery) and (ii) the amount of the indemnification payment previously made.
Section 7.7 Exclusive Remedy. Except in the case of fraud, intentional misconduct, claims for specific performance or injunctive relief, and rights arising under the Note Purchase Agreement or the Notes, the indemnification provisions set forth in this Article VII shall be the sole and exclusive remedy of the Parties after the Closing for any breach of this Agreement.
ARTICLE VIII
TERMINATION
Section 8.1 Termination. This Agreement may be terminated prior to the Closing: (a) by mutual written consent of Buyer and the Sellers; (b) by Buyer or the Sellers if the Closing has not occurred on or before the Outside Date, provided that such right shall not be available to any Party whose material breach has been the principal cause of such failure; (c) by Buyer if any representation of the Sellers or the Company becomes untrue or any of them breaches any covenant such that a condition in Section 6.2(a) or (b) would not be satisfied, and such breach is incapable of cure or has not been cured within fifteen (15) Business Days after written notice; (d) by the Sellers if any representation of Buyer becomes untrue or Buyer breaches any covenant such that a condition in Section 6.3(a) or (b) would not be satisfied, and such breach is incapable of cure or has not been cured within fifteen (15) Business Days after written notice; or (e) by Buyer or the Sellers if any Governmental Authority issues a final, non-appealable order permanently prohibiting the Closing.
Section 8.2 Effect of Termination. Upon termination pursuant to Section 8.1, this Agreement shall become void without liability of any Party, except that Section 5.4, this Section 8.2 and Article IX shall survive, and no termination shall relieve any Party from liability for fraud or willful and material breach prior to termination. If this Agreement is terminated prior to the Closing, the Note Purchase Agreement and the Notes shall not be executed or delivered and, if executed in anticipation of the Closing, shall be null and void ab initio.
ARTICLE IX
GENERAL PROVISIONS
Section 9.1 Governing Law. This Agreement and all disputes arising out of or relating to it shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to any choice or conflict of law rule that would result in the application of the laws of any other jurisdiction.
Section 9.2 Jurisdiction; Waiver of Jury Trial. The state courts of the State of New York located in Manhattan, New York County, and the United States District Court for the Southern District of New York shall have exclusive jurisdiction to hear and determine any dispute arising out of or in connection with this Agreement and the other Transaction Documents, and each Party irrevocably submits to such jurisdiction and waives any objection to venue or claim of inconvenient forum. EACH PARTY HEREBY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT.
Section 9.3 Notices. All notices hereunder shall be in writing and shall be deemed duly given (a) when delivered personally, (b) when sent by email, upon confirmation of receipt, if sent during normal business hours of the recipient (and otherwise on the next Business Day), or (c) one (1) Business Day after dispatch by internationally recognized overnight courier, in each case to the addresses set forth on Schedule 9.3, or to such other address as a Party may designate by notice in accordance with this Section 9.3.
Section 9.4 Entire Agreement. This Agreement, the Disclosure Schedule, the Exhibits, Schedules and Annexes hereto and the other Transaction Documents constitute the entire agreement among the Parties with respect to the subject matter hereof and supersede all prior agreements and understandings, including the term sheet relating to the transactions contemplated hereby.
Section 9.5 Amendments and Waivers. This Agreement may be amended only by a written instrument signed by Buyer and each Seller. No waiver shall be effective unless in writing and signed by the Party against whom it is to be enforced.
Section 9.6 Assignment. No Party may assign this Agreement or any of its rights or obligations hereunder without the prior written consent of Buyer and each Seller, and any purported assignment in violation hereof shall be null and void.
Section 9.7 Specific Performance. The Parties agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with its terms, and that the Parties shall be entitled to specific performance and injunctive relief, without proof of actual damages or posting of any bond, in addition to any other remedy at law or in equity. All remedies hereunder are cumulative.
Section 9.8 Severability. If any provision of this Agreement is held invalid, illegal or unenforceable, such provision shall be enforced to the maximum extent permissible, and the remaining provisions shall not be affected.
Section 9.9 Counterparts; Electronic Signatures. This Agreement may be executed in counterparts, each of which shall be an original and all of which together shall constitute one instrument. Signatures delivered by PDF or other electronic signature technology shall be effective for all purposes.
Section 9.10 Costs and Expenses. Each Party shall bear its own legal, accounting, tax and other transaction costs and expenses, except that Buyer shall bear Nasdaq filing fees, transfer agent fees and similar fees directly relating to the issuance of the Consideration Shares, the Notes and the Conversion Shares.
Section 9.11 Taxes. Each Party shall bear its own Taxes arising from the receipt of the Consideration Shares or the Notes, the transfer of the Shares or the receipt of the Conversion Shares, except as otherwise required by applicable law or expressly agreed in writing.
Section 9.12 No Third-Party Beneficiaries. Except for the provisions of Article VII with respect to the Buyer Indemnified Parties and the Seller Indemnified Parties, nothing in this Agreement shall confer any right or remedy on any Person other than the Parties and their respective successors and permitted assigns.
Section 9.13 Public Company Savings Clause. Notwithstanding anything to the contrary herein, no provision of this Agreement shall require Buyer to take any action that would, in the good faith advice of counsel, violate the Securities Act, the Exchange Act, SEC rules, the Nasdaq Rules or Cayman Islands law. To the extent any action contemplated hereby requires shareholder approval, Buyer’s obligation to take such action shall be subject to obtaining such approval.
Section 9.14 Foreign Private Issuer Status. If, after the Issue Date, Buyer ceases to be entitled to rely on foreign private issuer status or home country practice in a manner that materially affects the conversion mechanics of the Notes, the Parties shall cooperate in good faith as provided in the Note Purchase Agreement and the Notes so as to preserve the commercial intent of the transaction to the maximum extent legally permissible.
[Signature Pages Follow]
IN WITNESS WHEREOF, the Parties have executed this Stock Purchase Agreement as of the date first written above.
| BUYER: PMA GRAPHENE TECHNOLOGY GROUP INC. | ||
| By: | /s/ LIU Lei | |
| Name: | LIU Lei | |
| Title: | Chief Executive Officer | |
| Date: | November 18, 2026 |
| COMPANY: LANCHUANG TECHNOLOGY LIMITED | ||
| By: | /s/ CHEN Shangling | |
| Name: | CHEN Shangling | |
| Title: | Director | |
| Date: | November 18, 2026 |
IN WITNESS WHEREOF, the Parties have executed this Stock Purchase Agreement as of the date first written above.
| SELLER: KING MAX VALUE LIMITED | ||
| By: | /s/ Kelven WONG | |
| Name: | Kelven WONG | |
| Title: | Director | |
| Date: | November 18, 2026 |
** **
| SELLER: LANCHUANG HOLDINGS LIMITED | ||
| By: | /s/ CHEN Shangling | |
| Name: | CHEN Shangling | |
| Title: | Director | |
| Date: | November 18, 2026 |
Annex I — Sellers; Allocation of Purchase Price
| Seller | Shares Sold | % of Company | Share Consideration (US$) | Consideration Shares | Note Principal (US$) | Total (US$) | ||||||||||||||||||
| Lanchuang Holdings Limited | 25,500 | 51 | % | 41,437,500 | 31,875,000 | 91,162,500 | 132,600,000 | |||||||||||||||||
| King Max Value Limited | 24,500 | 49 | % | 39,812,500 | 30,625,000 | 87,587,500 | 127,400,000 | |||||||||||||||||
| Total | 50,000 | 100 | % | 81,250,000 | 62,500,000 | 178,750,000 | 260,000,000 |
Schedule 3.4 — Outstanding Instruments
None.
Schedule 3.5 — Subsidiaries; Businesses and Assets
Lanchuang (Hong Kong) Technology Limited (藍創(香港)科技有限公司), a limited company incorporated in Hong Kong on July 2, 2026 under the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) with company number 80750914, the entire issued share capital of which, being 10,000 fully paid shares issued for a total consideration of HK$10,000, is held by the Company, which was entered in its register of members as the holder of all such shares on July 17, 2026. Business and assets: the development and provision of Internet of Things (IoT) sensors and monitoring terminals, artificial intelligence (AI) algorithm models and cloud service platform solutions for ecological, environmental and production safety monitoring, serving government regulatory authorities and industrial enterprises.
Schedule 3.7 — Material Contracts
None.
Schedule 3.15 — Leased Real Property
None.
Schedule 9.3 — Notice Information
| PMA Graphene Technology Group Inc. (Buyer) | Office Unit B8, 27/F, NCB Innovation Centre, No. 888 Lai Chi Kok Road, Cheung Sha Wan, Kowloon, Hong Kong; Attention: [***] Email: [***] | |
| Lanchuang Holdings Limited (Seller) | Office Unit B8, 27/F, NCB Innovation Centre, No. 888 Lai Chi Kok Road, Cheung Sha Wan, Kowloon, Hong Kong; Attention: [***] Email: [***] | |
| King Max Value Limited (Seller) | Address: CCS Trustees Limited, Mandar House, 3rd Floor, Johnson’s Ghut, Tortola, British Virgin Islands; Attention: [***] Email: [***] | |
| Lanchuang Technology Limited (Company) | Address: CCS Trustees Limited, Mandar House, 3rd Floor, Johnson’s Ghut, Tortola, British Virgin Islands; Attention: [***] Email: [***] |
Exhibit A — Form of Convertible Note Purchase Agreement
CONVERTIBLE NOTE PURCHASE AGREEMENT
This Convertible Note Purchase Agreement (the “Agreement”) is made and entered into as of [●], 2026, by and among PMA Graphene Technology Group Inc. (formerly known as Ming Shing Group Holdings Limited), an exempted company incorporated with limited liability under the laws of the Cayman Islands (the “Company”), whose Class A ordinary shares, par value $0.0005 per share (the “Class A Ordinary Shares”), are listed on The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker “PMA,” and the purchasers listed on Annex I hereto (the “Purchasers”), solely in their capacity as Sellers under the Acquisition Agreement (as hereinafter defined).
RECITAL
On the terms and subject to the conditions set forth herein, in connection with that certain stock purchase agreement, dated as of November 18, 2026 (the “Acquisition Agreement”) by and among the Company, the Purchasers (in their capacity as “Sellers” under the Acquisition Agreement), and Lanchuang Technology Limited, a British Virgin Islands Business Company (the “Target”), Purchasers desire to purchase from the Company, and the Company desires to sell and issue to the Purchasers, convertible promissory notes in the aggregate original principal amount of $178,750,000.00 in the amounts and proportions set forth on Annex I hereto, as a portion of the consideration pursuant to the terms of the Acquisition Agreement as further described below.
Agreement
NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises, representations, warranties, and covenants hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
| 1. | Definitions. |
| 1.1. | Capitalized terms used but not otherwise defined herein shall have the meanings given to them in the Acquisition Agreement. The following terms and expressions used in this Agreement, unless the context otherwise requires, shall have the following meanings: |
“Conversion Shares” means the Class A Ordinary Shares issuable upon conversion of the Notes.
“Conversion Price” has the meaning given to it in the Form of Note attached as Exhibit A hereto.
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Financial Forecast” means the written financial forecast provided by the Target to the Company, and as set forth as Annex II hereto, including, without limitation, all accounting assessments, forecasts, estimates and methodologies set forth therein.
“GAAP” means generally accepted accounting principles in the United States set forth in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board.
“Material Adverse Effect” means any event, change, effect, development, circumstance or occurrence that, individually or in the aggregate, materially impairs the Company’s ability to consummate the transactions contemplated by this Agreement or the Notes.
“Nasdaq Rules” means the Nasdaq Listing Rules, including, without limitation, Rules 5110(a), 5250(e)(2), 5615(a)(3), 5635(a), 5635(b), 5635(d), 5640, and the applicable interpretive materials thereof.
“Notes” means the convertible promissory notes substantially in the form attached hereto as Exhibit A issued to the Purchasers, which notes constitutes the “Notes” for purposes of the Acquisition Agreement.
“Performance Schedule” means the schedule attached hereto as Schedule 1 setting forth, for each Performance Year, the Performance Target and the agreed metrics, thresholds and measurement basis.
“Performance Tranche Limitation” means the restriction set forth in Section 6.4 hereof pursuant to which no portion of the Principal Amount corresponding to an Annual Performance Tranche may be converted unless and until the applicable Performance Target has been satisfied and a Conversion Eligibility Notice has been delivered in respect of such Annual Performance Tranche.
“Principal Amount” shall mean the aggregate original principal amount of the Notes of $178,750,000.00.
“SEC” means the U.S. Securities and Exchange Commission.
“SEC Reports” means, collectively, the Company’s annual reports on Form 20-F, current reports on Form 6-K and any registration statements, prospectuses or other reports or documents filed with or furnished to the SEC under the Securities Act or the Exchange Act since January 1, 2026.
“Signing Date” means the date of this Agreement.
“Securities Act” shall mean the Securities Act of 1933, as amended.
“Transaction Documents” shall mean, collectively, the Acquisition Agreement, this Agreement, the Notes, and all certificates, instruments, opinions and other agreements executed and delivered in connection therewith or herewith, each as amended or otherwise modified from time to time, and all modifications, renewals, replacements, extensions and rearrangements thereof and substitutions and replacements therefor.
| 2. | Agreement To Sell and Purchase. |
| 2.1. | Issuance of Notes at Closing. |
| a. | Closing. Subject to the terms and conditions of this Agreement, at the Closing, the Company agrees to issue and sell to the Purchasers participating in the Closing, and the Purchasers (severally and not jointly) agree to purchase from the Company the Notes in the proportions set forth on Annex I hereto in the aggregate amount of the Principal Amount. |
| b. | Purchase Price. The Parties acknowledge and agree that the Principal Amount constitutes the note portion of the purchase price payable by the Company under the Acquisition Agreement, with the balance of the purchase price being satisfied by the issuance of Class A Ordinary Shares to the Purchasers under the Acquisition Agreement. The note portion of the purchase price shall be satisfied solely by the issuance of the Notes. |
| 2.2. | Pari Passu. The Notes shall constitute a senior direct, unsecured, unsubordinated obligation of the Company and shall rank pari passu with all present and future unsecured and unsubordinated obligations of the Company, except as obligations may be preferred by laws of general application. |
| 2.3. | Use of Proceeds. The Parties acknowledge that no cash proceeds will be advanced by the Purchasers to the Company at the Closing. The Notes are being issued solely as non-cash acquisition consideration pursuant to the Acquisition Agreement and not for working capital or general corporate purposes. |
| 3. | Closing, Delivery and Conditions Precedent. |
** **
| 3.1. | Closing. The closing of the sale and purchase of the Notes under this Agreement (the “Closing”) shall take place remotely concurrently with the closing under the Acquisition Agreement, at such time or place as the Company and the Purchasers may mutually agree (such date is hereinafter referred to as the “Closing Date”). |
| 3.2. | Delivery; Consideration. Subject to the terms of this Agreement, at the Closing, the Company will deliver to the Purchasers the duly executed Notes against the Purchasers’ delivery of the Acquisition Agreement closing deliverables, and the purchase price for the Notes shall be deemed paid and satisfied in full upon such issuance and delivery. No cash payment shall be due from the Purchasers to the Company at the Closing under this Agreement. |
| 3.3. | Conditions Precedent to the Purchasers’ Obligations. Each Purchaser’s obligation to purchase their respective Note at the Closing is subject to the satisfaction, at or prior to the Closing Date, of each of the following conditions: |
| a. | the representations and warranties of the Company in Section 4 hereof shall be true and correct in all material respects as of the Closing Date; |
| b. | the Company shall have performed in all material respects all obligations required to be performed by it under this Agreement on or prior to the Closing Date; |
| c. | the Company shall have obtained all corporate approvals and authorizations required for the execution, delivery and performance of the Transaction Documents and the issuance of the Notes and reservation of the Conversion Shares; |
| d. | all conditions precedent for the closing contemplated by the Acquisition Agreement shall have been satisfied or waived in accordance with the Acquisition Agreement; |
| e. | the Purchasers shall have received evidence reasonably satisfactory to it that the Company has submitted any required Listing of Additional Shares notification under Nasdaq Rule 5250(e)(2) with respect to the potential issuance of the Conversion Shares, that any initial listing approval required under Nasdaq Rule 5110(a) has been obtained, and that no objection has been raised by Nasdaq prior to Closing; and |
| f. | no law, order or injunction of any Governmental Authority shall be in effect that restrains, enjoins or otherwise prohibits consummation of the transactions contemplated hereby. |
| 3.4. | Conditions Precedent to Company’s Obligations. The Company’s obligation to issue and sell the Notes at the Closing is subject to the satisfaction, at or prior to the Closing Date, of each of the following conditions: |
| a. | the representations and warranties of the Purchasers in Section 5 hereof shall be true and correct in all material respects as of the Closing Date; |
| b. | the Purchasers shall have performed in all material respects all obligations required to be performed by them under this Agreement on or prior to the Closing Date; |
| c. | the delivery of the Financial Forecast in form and substance reasonably satisfactory to the Company, prepared on a basis consistent with the Performance Schedule; |
| d. | the Purchasers shall have obtained all organizational approvals and authorizations required for the execution, delivery and performance of the Transaction Documents to which each is a party; and |
| e. | all conditions precedent for the closing contemplated by the Acquisition Agreement shall have been satisfied or waived in accordance with the Acquisition Agreement. |
| 4. | Representations And Warranties Of The Company. |
Except as disclosed in the SEC Reports, the Company hereby represents and warrants to the Purchaser as of the Signing Date and as of the Closing Date as follows:
| 4.1. | Organization; Subsidiaries; Good Standing; Power. The Company is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands and has all requisite corporate power and authority to own and operate its properties and assets and to carry on its business as presently conducted. Each subsidiary of the Company is duly organized, validly existing and, where applicable, in good standing under the laws of its jurisdiction of organization, except where such failure would not reasonably be expected to have a Material Adverse Effect. |
| 4.2. | Authorization; Binding Obligations. All corporate action on the part of the Company, its directors and officers necessary for the authorization, execution, delivery and performance of the Transaction Documents, the issuance of the Notes and the reservation and issuance of the Conversion Shares has been taken. The Transaction Documents constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws and general principles of equity. |
| 4.3. | No Conflicts; Consents and Approvals. The execution, delivery and performance of the Transaction Documents by the Company, and the issuance of the Notes and the Conversion Shares, do not: |
| a. | conflict with the Company’s memorandum and articles of association (“M&A”); |
| b. | violate any law, rule, regulation, order or decree applicable to the Company; |
| c. | result in a material breach or default under any material contract to which the Company is a party, except as would not reasonably be expected to have a Material Adverse Effect. |
No consent, approval, authorization, order, registration or qualification of or with any court or Governmental Authority is required in connection with the execution, delivery and performance by the Company of the Transaction Documents, except for (i) required Nasdaq notifications, including any Listing of Additional Shares, and (ii) such consents, approvals or filings the failure of which to obtain or make would not reasonably be expected to have a Material Adverse Effect.
| 4.4. | Capitalization; Valid Issuance; Preemptive Rights. The authorized share capital of the Company is as set forth in the Company’s SEC Reports indicating such information. The issued and outstanding share capital of the Company is as set forth in the Company’s SEC Reports as of the dates stated therein. The Conversion Shares have been duly authorized for issuance and, when issued upon conversion of the Notes in accordance with their terms and in compliance with applicable Nasdaq Rules (including obtaining any required shareholder approval), will be validly issued, fully paid and nonassessable, and will not be issued in violation of any preemptive rights, rights of first refusal or similar rights of any person (to the Company’s knowledge, with respect to any third-party contractual rights). The Company has duly reserved, and shall at all times keep reserved, out of its authorized but unissued Class A Ordinary Shares, a number of Class A Ordinary Shares sufficient to permit the issuance of the Conversion Shares upon conversion of the then outstanding principal amount of the Notes at the fixed Conversion Price, in each case subject to the limitations set forth in the Notes, the Nasdaq Rules, the Beneficial Ownership Limitation and Performance Tranche Limitation. |
** **
** **
| 4.5. | SEC Reports; No Material Misstatement or Omission. Since January 1, 2026, the Company has filed with or furnished to the SEC all forms, reports, schedules, statements and other documents required to be filed or furnished by it as a foreign private issuer under the Exchange Act and the Securities Act. As of their respective dates (or, if amended or supplemented, as of the date of the last such amendment or supplement), the SEC Reports complied in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and none of the SEC Reports, when filed or furnished, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances under which they were made. |
** **
| 4.6. | Financial Statements; Internal Controls; Disclosure Controls. The financial statements included in the SEC Reports comply in all material respects with applicable accounting requirements and have been prepared in conformity with GAAP as issued by the Financial Accounting Standards Board, applied on a consistent basis (except as disclosed therein), and fairly present in all material respects the consolidated financial condition and results of operations of the Company and its consolidated subsidiaries as of the dates and for the periods indicated. The Company maintains disclosure controls and procedures and internal control over financial reporting (as such terms are defined in the Exchange Act), and has disclosed to its auditors and the audit committee of its board of directors (a) any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information, and (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls; and any such disclosures have been disclosed in the SEC Reports where required. |
** **
| 4.7. | Listing; Reporting; FPI Status; Transfer Agent. The Class A Ordinary Shares are registered under Section 12 of the Exchange Act and are listed on Nasdaq. The Company is a “foreign private issuer” and is in compliance in all material respects with its reporting obligations under the Exchange Act applicable to foreign private issuers. The Company has a duly appointed transfer agent and registrar for the Class A Ordinary Shares. |
** **
| 4.8. | Nasdaq Compliance; Voting Rights. The issuance of the Notes and the potential issuance of the Conversion Shares will comply in all material respects with applicable Nasdaq Rules, including Rules 5110(a), 5635(a), 5635(b) and 5635(d), subject to the pricing, caps and limitations set forth in the Notes and this Agreement, any applicable home country practice exemption disclosed pursuant to Nasdaq Rule 5615(a)(3), and any shareholder approval obtained after the Signing Date, if applicable. The Company is not in violation of Nasdaq Rule 5640 (Voting Rights). |
** **
| 4.9. | Private Placement; No Registration; No Integrated Offering; No General Solicitation. Assuming the accuracy of the Purchasers’ representations in Section 5 hereof, the offer, sale and issuance of the Notes pursuant to this Agreement are exempt from the registration requirements of the Securities Act pursuant to Regulation S. Neither the Company nor, to the Company’s knowledge, any person acting on its behalf has engaged in any form of general solicitation or general advertising in connection with the offer or sale of the Notes. Neither the Company nor, to the Company’s knowledge, any of its affiliates has, directly or through any agent, engaged in any integration of this offering with any other offering of the Company’s securities that would require registration of the Notes under the Securities Act. |
** **
| 4.10. | Rule 506(d) Bad Actor. The Company has exercised reasonable care to determine whether any “covered person” of the Company is subject to a disqualifying event under Rule 506(d) of Regulation D and is not aware of any such disqualifying event, except for disqualifying events covered by Rule 506(d)(2) or (d)(3) that have been disclosed in writing to the Purchasers. |
** **
** **
| 4.11. | Investment Company Act. The Company is not, and after giving effect to the transactions contemplated by the Transaction Documents will not be, an “investment company” as defined in the Investment Company Act of 1940, as amended. |
** **
| 4.12. | No Stop Orders; No Manipulation. No stop order suspending the effectiveness of any registration statement of the Company has been issued and no proceedings for that purpose have been instituted or, to the Company’s knowledge, threatened by the SEC. The Company has not taken, directly or indirectly, any action intended to cause or reasonably likely to result in the stabilization or manipulation of the price of any security of the Company. |
** **
| 4.13. | Home Country Practice; Nasdaq Rule 5615(a)(3). The Company is a “foreign private issuer” within the meaning of the Exchange Act and, as such, is permitted under Nasdaq Listing Rule 5615(a)(3) to follow the corporate governance practices of its home country in lieu of certain Nasdaq corporate governance requirements, except as to those Nasdaq Rules that are expressly ineligible for such exemption. To the extent the Company elects to follow home country practice in lieu of any Nasdaq corporate governance requirement, the Company has made, or will make on a timely basis, the disclosures required by Nasdaq Listing Rule 5615(a)(3) (including disclosure in the Company’s SEC Reports and, as applicable, on its website) identifying each Nasdaq corporate governance requirement from which it departs and describing the home country practices it follows. The execution, delivery and performance of the Transaction Documents, and the issuance of the Notes and the Conversion Shares, have been authorized, approved and taken in compliance in all material respects with applicable laws of the Cayman Islands and the M&A and, to the extent applicable, in accordance with the Company’s disclosed home country practices under Nasdaq Listing Rule 5615(a)(3). No approval of the Company’s shareholders is required under the laws of the Cayman Islands, the M&A or the Company’s disclosed home country practices in connection with the execution, delivery and performance of the Transaction Documents and the issuance of the Notes and the reservation of the Conversion Shares, and the Company is at the date of this Agreement, and will be as of the date of the issuance of the Notes, eligible for an exemption from shareholder approval requirements under Nasdaq Listing Rule 5635 (including without limitation Rules 5635(a), 5635(b) and 5635(d)) in accordance with the Company’s disclosed home country practices under Nasdaq Listing Rule 5615(a)(3), provided, however, that to the extent any issuance of Conversion Shares would require shareholder approval under Nasdaq Rule 5635, the Company shall not be obligated to issue, and the Holder shall not be entitled to receive, such Conversion Shares unless and until such approval has been obtained or the Company has confirmed, on the advice of counsel and following consultation with Nasdaq, that an exemption is available. |
** **
| 4.14. | No Financial Assistance Issues; Brokers. Under Cayman Islands law, there is no prohibition on the Company providing financial assistance in connection with the acquisition of its own shares, and the execution and performance of the Transaction Documents will not violate any financial assistance restriction. No agent, broker, investment banker, person or firm acting on behalf of or under the authority of the Company is or will be entitled to any broker’s or finder’s fee or any other commission directly or indirectly in connection with the transactions contemplated hereby, except as has been disclosed in writing to the Purchasers. |
** **
| 5. | Representations And Warranties of Purchasers |
** **
Each Purchaser, severally and not jointly hereby represents and warrants to the Company as of the Signing Date and as of the Closing Date as follows:
| 5.1. | Organization; Power; Authority. The Purchaser is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization and has full power and authority to execute, deliver and perform this Agreement and the other Transaction Documents. This Agreement and the other Transaction Documents constitute valid and binding obligations of the Purchaser, enforceable against the Purchaser in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws and general principles of equity. |
** **
** **
| 5.2. | Regulation S Compliance. |
** **
| a. | At the time hereof, the Purchaser is physically outside the United States. |
| b. | The Purchaser is acquiring their respective Note and any Conversion Shares for such Purchaser’s own account, for investment and not for distribution or resale to others and is not purchasing their respective Note and any Conversion Shares for the account or benefit of any U.S. person, or with a view towards distribution to any U.S. person, in violation of the registration requirements of the Securities Act. |
| c. | The Purchaser will make all subsequent offers and sales of their respective Note and any Conversion Shares either (x) outside of the United States in compliance with Regulation S; (y) pursuant to a registration under the Securities Act; or (z) pursuant to an available exemption from registration under the Securities Act. Specifically, the Purchaser will not resell their respective Note or any Conversion Shares to any U.S. person or within the United States prior to the expiration of a period commencing on the Closing Date and ending on the date that is one year thereafter (the “Distribution Compliance Period”), except pursuant to registration under the Securities Act or an exemption from registration under the Securities Act. |
| d. | The Purchaser has no present plan or intention to sell their respective Note or any Conversion Shares in the United States or to a U.S. person at any predetermined time, has made no predetermined arrangements to sell their respective Note or any Conversion Shares and is not acting as a distributor of such securities. |
| e. | Neither the Purchaser, its Affiliates nor any Person acting on behalf of such Purchaser, has entered into, has the intention of entering into, or will enter into any put option, short position or other similar instrument or position in the U.S. with respect to their respective Note or any Conversion Shares at any time after the Closing Date through the Distribution Compliance Period except in compliance with the Securities Act. |
| f. | The Purchaser is not acquiring the Note or the Conversion Shares in a transaction (or an element of a series of transactions) that is part of any plan or scheme to evade the registration provisions of the Securities Act. |
| g. | The Purchaser has sufficient knowledge and experience in finance, securities, investments and other business matters to be able to protect the Purchaser’s interests in connection with the transactions contemplated by this Agreement and other Transaction Documents. |
| h. | The Purchaser has consulted, to the extent that it has deemed necessary, with its tax, legal, accounting and financial advisors concerning its investment in the Note and the Conversion Shares. |
| i. | The Purchaser understands the various risks of an investment in the Note and the Conversion Shares and can afford to bear such risks for an indefinite period of time, including, without limitation, the risk of losing its entire investment in the Note and the Conversion Shares. |
| 5.3. | No General Solicitation. The Purchaser is not purchasing their respective Note as a result of any general solicitation or general advertising. |
** **
** **
| 5.4. | Rule 506(d) Bad Actor. Neither the Purchaser nor, to its knowledge, any of its affiliates is subject to a disqualifying event under Rule 506(d) that would require disclosure and has provided such information as the Company reasonably requested to permit the Company to comply with Rule 506(d). |
** **
| 5.5. | Access to Information; Sophistication; Restricted Securities; Legends. The Purchaser has had an opportunity to discuss the Company’s business, management and financial affairs with the Company and has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of its investment and is able to bear the economic risk of an investment in their respective Note and any Conversion Shares. The Purchaser understands that their respective Note and the Conversion Shares have not been registered under the Securities Act or any state securities laws and are “restricted securities” under the Securities Act and applicable state securities laws and that their respective Note and the Conversion Shares may not be offered, sold or otherwise transferred except pursuant to an effective registration statement or an available exemption from registration. The Purchaser acknowledges and agrees that their respective Note and any certificates or book-entry statements representing the Conversion Shares will bear customary restrictive legends (or notations) under the Securities Act and applicable state law and that the Company, its transfer agent and their respective counsel may place and maintain such legends (or notations) and stop-transfer instructions until such time as the removal of any legend (or notation) is permitted under applicable law and, if requested by the Company or its transfer agent, the Purchaser has delivered to the Company such certificates, agreements, representations and legal opinions of counsel reasonably satisfactory to the Company and its counsel as the Company or its transfer agent may reasonably require to evidence compliance with the Securities Act and applicable state securities laws, including in connection with any proposed resale under Rule 144. |
** **
| 5.6. | Sanctions; AML; Anti-Corruption; No Group; No Short Sales. The Purchaser is in compliance with applicable sanctions, anti-money laundering and anti-corruption laws. The Purchaser is not a member of a “group” (as such term is used in Section 13(d) of the Exchange Act) with respect to the Company, except as disclosed in writing to the Company. As of the date hereof, the Purchaser does not have an open short position in the Class A Ordinary Shares and will not enter into any short sale or similar transaction that establishes a net short position with respect to the Class A Ordinary Shares during the period from the date of the Acquisition Agreement until the earlier of (a) public announcement of the transactions contemplated hereby and (b) the Closing. |
** **
| 5.7. | Transfer Procedures. Without limiting Section 5.5 hereof, the Purchaser consents to the placement of restrictive legends (or book-entry notations) on their respective Note and any Conversion Shares and to the entry of customary stop-transfer instructions with the Company’s transfer agent, and agrees that any removal of legends (or notations) and any transfers shall be effected in compliance with the Securities Act and applicable state securities laws, the terms of the Transaction Documents, and the Company’s and its transfer agent’s reasonable procedures, including the provision of customary seller and broker certificates and legal opinions of counsel reasonably satisfactory to the Company and its counsel in connection with any proposed resale under Rule 144 or other available exemption. |
** **
| 5.8. | Financial Forecast. The Financial Forecast, including the forecast performance for each Performance Year, has been prepared in good faith based on assumptions believed by the Target and the Purchasers to be reasonable at the time of preparation, and that all material assumptions, limitations and dependencies relevant to the Financial Forecast have been fairly disclosed to the Company. |
** **
** **
| 6. | Covenants. |
** **
| 6.1. | Covenants of the Company. For so long as the Notes remain outstanding, the Company shall: |
| a. | Remain duly incorporated, validly existing and in good standing under the laws of the Cayman Islands and retain all requisite corporate power and authority to own and operate its properties and assets and to carry on its business as presently conducted, except where failure to do so would not reasonably be expected to have a Material Adverse Effect; |
| b. | Maintain its listing on the Nasdaq, subject to market and regulatory conditions beyond its reasonable control, and shall make any Listing of Additional Shares notification to Nasdaq required under Rule 5250(e)(2) in respect of the Notes and the Conversion Shares within the time required thereby, and shall otherwise comply with applicable Nasdaq Rules, including Rules 5635(b), 5635(d) and 5640; |
| c. | Refrain from taking any action with the primary purpose of frustrating or preventing lawful conversion of the Notes in accordance with their terms; |
| d. | Comply with all applicable laws, including without limitation its reporting obligations under the Exchange Act and the Nasdaq Rules, except where failure to do so would not reasonably be expected to have a Material Adverse Effect; |
| e. | promptly notify the Purchasers of any event that would reasonably be expected to materially affect the convertibility, enforceability or value of the Notes; |
| f. | reserve and keep available out of its authorized but unissued Class A Ordinary Shares, free of preemptive rights, such number of Class A Ordinary Shares as shall be sufficient to effect the conversion in full of the outstanding principal amount of the Notes at the fixed Conversion Price, subject to the limitations in the Notes, applicable law, the Nasdaq Rules, any required shareholder approval, the Beneficial Ownership Limitation, and Performance Tranche Limitation; and |
| g. | furnish such information and confirmations as the Purchasers may reasonably require in connection with any proposed conversion and compliance with the Beneficial Ownership Limitation, and Performance Tranche Limitation. |
| 6.2. | Covenants of the Purchasers. |
** **
| a. | For so long as the Notes remain outstanding, each Purchaser shall not effect any conversion, transfer or other arrangement designed to circumvent the Beneficial Ownership Limitation, or Performance Tranche Limitation, whether through nominees, affiliates, derivative arrangements or otherwise; and |
| b. | For so long as any Annual Performance Tranche (as hereinafter defined) remains outstanding and non-convertible, each Purchaser shall, to the extent it has the legal right or practical ability to do so, use its best efforts to cause the Target to provide the Company with financial statements, management accounts, supporting schedules, tax computations and other information reasonably required by the Company to determine the actual performance of the Target for the relevant Performance Year and whether the applicable Performance Target (as hereinafter defined) has been satisfied in accordance with Section 6.4. |
| 6.3. | Beneficial Ownership Limitation. For so long as any portion of aggregate principal of the Notes is outstanding, notwithstanding anything to the contrary contained in the Notes or the Transaction Documents, the Company shall not effect any conversion of the Notes, and the Purchasers shall not have the right to convert any portion of the Notes, if immediately after giving effect to such conversion, the Purchaser, together with its affiliates, its beneficial owner(s) and any other persons whose beneficial ownership would be aggregated with the Purchaser under Section 13(d) of the Exchange Act, would directly or indirectly beneficially own more than 9.99% of the then issued and outstanding Class A Ordinary Shares (the “Beneficial Ownership Limitation”). For the avoidance of doubt, the Beneficial Ownership Limitation shall apply to all Class A Ordinary Shares beneficially owned by the Purchaser and such persons, including the Consideration Shares and Conversion Shares previously issued. Each Purchaser shall provide, together with each conversion notice required under the terms of the Notes, a certification of its then current beneficial ownership, its ultimate beneficial owner(s), any persons required to be aggregated with it, and such supporting information as the Company may reasonably require to confirm compliance with the Beneficial Ownership Limitation. The Beneficial Ownership Limitation shall not be increased above 9.99% unless expressly agreed by the Company and the relevant Purchaser and only to the extent legally permissible under applicable securities laws, Nasdaq rules and the Company’s corporate approvals. |
| 6.4. | Performance Tranche Limitation and Conversion Eligibility. |
** **
| a. | For the purposes of determining conversion eligibility, the Principal Amount shall be divided into three annual performance tranches of one-third each (subject to the rounding reflected on Annex I hereto) (each, an “Annual Performance Tranche” and collectively, the “Annual Performance Tranches”), and the portion of each Annual Performance Tranche allocated to each Purchaser shall be as set forth on Annex I hereto. The Annual Performance Tranches shall correspond respectively to the three financial periods specified in the Performance Schedule. Each such financial period is referred to herein as a “Performance Year,” and collectively, the “Performance Years.” |
| b. | The portion of the Principal Amount corresponding to an Annual Performance Tranche shall be eligible for conversion only after completion of the relevant Performance Year and only if the Target achieves the performance target specified for such Performance Year in the Performance Schedule (the “Performance Target”). Each Annual Performance Tranche shall be assessed separately and solely by reference to the corresponding Performance Year. Only the metrics and thresholds expressly agreed in the Performance Schedule shall determine conversion eligibility unless expressly agreed by the Company in writing. |
| c. | Within sixty (60) days after the end of the relevant Performance Year, the Company, acting reasonably and in good faith, shall determine, on the basis of the financial information of the Target and its subsidiaries available to the Company as their parent company (including management accounts and consolidation records), whether the applicable Performance Target has been satisfied. No audit of the financial statements of the Target for any Performance Year shall be required for the purposes of such determination. If the Company determines that the applicable Performance Target has been satisfied, it shall promptly notify the applicable Purchaser in writing of such determination (a “Conversion Eligibility Notice”), and the relevant Annual Performance Tranche shall become eligible for conversion on the date of such notice. If the Company determines that the applicable Performance Target has not been satisfied, it shall promptly notify the applicable Purchaser in writing of such determination, together with reasonable supporting calculations. The Company’s determination under this Section 6.4(c) shall be final and binding on the Purchasers absent manifest error. No Annual Performance Tranche may be converted unless and until the Company has delivered a Conversion Eligibility Notice in respect of such Annual Performance Tranche. Once an Annual Performance Tranche becomes eligible for conversion, it shall remain eligible for conversion until converted, redeemed, repurchased or otherwise cancelled in accordance with the terms of the applicable Note. |
| d. | If it is not determined, pursuant to Section 6.4(c), that the applicable Performance Target has been satisfied, the relevant Annual Performance Tranche shall remain outstanding but shall not be convertible unless otherwise expressly agreed by the Company in writing. For the avoidance of doubt, the satisfaction of the Performance Target for any subsequent Performance Year shall not render convertible any Annual Performance Tranche relating to a prior Performance Year that failed to satisfy the applicable Performance Target. |
| 7. | Miscellaneous. |
** **
| 7.1. | Governing Law. This Agreement shall be governed by and construed under the internal laws of the State of New York without giving effect to conflicts of laws principles that would result in the application of the law of another jurisdiction. The state courts of the State of New York located in Manhattan, New York County, and the United States District Court for the Southern District of New York shall have exclusive jurisdiction to hear and determine any dispute arising out of or in connection with this Agreement and the Notes and the related definitive documents, and each party irrevocably submits to such jurisdiction. THE PARTIES TO THIS AGREEMENT HEREBY WAIVE THEIR RIGHT TO A TRIAL BY JURY WITH RESPECT TO DISPUTES ARISING UNDER THIS AGREEMENT AND THE RELATED AGREEMENTS AND CONSENT TO A BENCH TRIAL WITH THE APPROPRIATE JUDGE ACTING AS THE FINDER OF FACT. |
** **
| 7.2. | Survival. The representations, warranties, covenants and agreements made herein shall survive the closing of the transactions contemplated hereby for the periods set forth in Section 7.1 of the Acquisition Agreement, and otherwise in accordance with their terms. All statements as to factual matters contained in any certificate or other instrument delivered by or on behalf of the Company pursuant hereto in connection with the transactions contemplated hereby shall be deemed to be representations and warranties by the Company hereunder solely as of the date of such certificate or instrument. |
** **
| 7.3. | Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon the parties hereto and their respective successors, assigns, heirs, executors and administrators and shall inure to the benefit of and be enforceable by each person who shall be a holder of the Notes from time to time; provided, however, the Purchasers may not sell, assign, transfer, convey or pledge any interest in the Notes except in compliance with the Securities Act, applicable state securities laws, the terms of the Transaction Documents, and the reasonable procedures of the Company and its transfer agent, including the delivery of customary certificates and legal opinions reasonably requested in connection with any proposed transfer. |
** **
| 7.4. | Entire Agreement. This Agreement, the Acquisition Agreement, the Notes, the Exhibits and Annexes hereto, the other Transaction Documents and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof and no party shall be liable or bound to any other in any manner by any oral or written representations, warranties, covenants and agreements except as specifically set forth herein and therein. Each party expressly represents and warrants that it is not relying on any oral or written representations, warranties, covenants or agreements outside of this Agreement, the Acquisition Agreement, the Notes, and the other Transaction Documents. |
** **
| 7.5. | Severability; Counterparts; Electronic Signatures. In the event one or more of the provisions of this Agreement should, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein. This Agreement may be executed in counterparts and by electronic signatures that comply with the U.S. federal ESIGN Act of 2000. |
** **
** **
| 7.6. | Amendment and Waiver; Termination. This Agreement and the Notes may be amended, waived or modified only by a written instrument signed by the Company and each Purchaser affected thereby, or, where the amendment, waiver or modification affects all Purchasers or the overall structure of the transaction, the Company and all Purchasers. |
** **
| 7.7. | Public Company and Nasdaq Compliance Savings Clause. Notwithstanding anything to the contrary contained in this Agreement, no provision of this Agreement shall require the Company or any of its Affiliates to take any action that would, in the good faith advice of counsel, violate the Securities Act, the Exchange Act, applicable SEC rules and regulations, applicable Nasdaq Rules or Cayman Islands law. To the extent any action contemplated hereby would require shareholder approval under applicable Nasdaq Rules or Cayman Islands law, the Company’s obligation to take such action shall be subject to obtaining such approval, and until such approval is obtained the applicable provisions of this Agreement and the Notes shall be interpreted and applied in a manner intended to preserve compliance. |
** **
| 7.8. | Notices. All notices, requests, demands, consents, waivers and other communications required or permitted hereunder or under the Notes shall be in writing and shall be given in the manner, and deemed duly given at the times, set forth in Section 9.3 of the Acquisition Agreement, which is incorporated herein by reference, mutatis mutandis, as if set forth in full herein, such that any such notice shall be deemed duly given (a) when delivered personally, (b) when sent by email, upon confirmation of receipt, if sent during normal business hours of the recipient (and otherwise on the next Business Day), or (c) one (1) Business Day after dispatch by internationally recognized overnight courier. Notices shall be delivered (i) if to the Company, to the address, attention and email set forth for Buyer on Schedule 9.3 to the Acquisition Agreement, and (ii) if to a Purchaser, to the address, attention and email set forth for such Purchaser (in its capacity as a Seller) on Schedule 9.3 to the Acquisition Agreement, or, in each case, to such other address as a party may designate by notice given in accordance with this Section. Any holder of a Note that is not a party to the Acquisition Agreement shall designate its notice details to the Company in writing upon becoming a holder, and notices to such holder shall be given in accordance with this Section to the details so designated. Any change of notice details made in accordance with Section 9.3 of the Acquisition Agreement shall be deemed made for purposes of this Agreement, and vice versa. |
** **
| 7.9. | Delays or Omissions. It is agreed that no delay or omission to exercise any right, power or remedy accruing to any party, upon any breach, default or noncompliance by another party under this Agreement, the other Transaction Documents, shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on any party’s part of any breach, default or noncompliance under this Agreement or the other Transaction Documents or any waiver on such party’s part of any provisions or conditions of this Agreement or the other Transaction Documents must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or the other Transaction Documents by law, or otherwise afforded to any party, shall be cumulative and not alternative. |
** **
[Signature Page Follows]
IN WITNESS WHEREOF, the parties have executed this Convertible Note Purchase Agreement as of the date first written above.
| COMPANY: PMA GRAPHENE TECHNOLOGY GROUP INC. | PURCHASER: LANCHUANG HOLDINGS LIMITED | |||
| By: | By: | |||
| Name: | LIU Lei | Name: | CHEN Shangling | |
| Title: | Chief Executive Officer | Title: | Director | |
| Date: | Date: |
| PURCHASER: KING MAX VALUE LIMITED | ||
| By: | ||
| Name: | Kelven WONG | |
| Title: | Director | |
| Date: |
Annex I — Purchasers; Notes; Annual Performance Tranches
| Purchaser | Principal Amount of Note | Performance Tranche Year 1 | Performance Tranche Year 2 | Performance Tranche Year 3 | ||||||||||||
| Lanchuang Holdings Limited | $ | 91,162,500.00 | $ | 30,387,500.00 | $ | 30,387,500.00 | $ | 30,387,500.00 | ||||||||
| King Max Value Limited | $ | 87,587,500.00 | $ | 29,195,833.33 | $ | 29,195,833.33 | $ | 29,195,833.34 | ||||||||
| TOTAL | $ | 178,750,000.00 | $ | 59,583,333.33 | $ | 59,583,333.33 | $ | 59,583,333.34 |
Annex II — Financial Forecast

Schedule 1 — Performance Schedule
Performance Years. (a) Performance Year 1 is the period of twelve (12) months commencing on (and including) the Closing Date; (b) Performance Year 2 is the period of twelve (12) months immediately following the end of Performance Year 1; and (c) Performance Year 3 is the period of twelve (12) months immediately following the end of Performance Year 2.
Performance Target. The Performance Target for each Performance Year is that the Performance NPAT for that Performance Year is not less than the amount in Renminbi (“RMB”) set out below for that Performance Year, being the net profit after income tax forecast for the corresponding year in the Financial Forecast:
(a) Performance Year 1 (Year 1 of the Financial Forecast): RMB10,000,000;
(b) Performance Year 2 (Year 2 of the Financial Forecast): RMB22,000,000; and
(c) Performance Year 3 (Year 3 of the Financial Forecast): RMB53,000,000.
Performance NPAT. “Performance NPAT” means, for any Performance Year, the consolidated net profit after income tax of the Target and its subsidiaries for that Performance Year, determined in accordance with GAAP consistently applied and on the basis set out in Section 6.4(c), excluding: (a) any depreciation, amortization, impairment or other charge arising from fair value adjustments, intangible assets or goodwill recognized by the Company in accounting for its acquisition of the Target; (b) any costs and expenses of the transactions contemplated by the Transaction Documents and any accounting effect of the Notes or the Consideration Shares; (c) any income or gain that is non-recurring or arises outside the ordinary course of business of the Target and its subsidiaries; (d) any income or profit arising from any transaction with any Purchaser or any Related Party (as defined in the Acquisition Agreement), unless entered into on arm’s-length terms with the prior written approval of the Company; and (e) any management fee or other charge levied by the Company or any of its other subsidiaries on the Target or its subsidiaries, except to the extent it reflects the arm’s-length cost of services actually provided to them.
Consolidation Perimeter. Performance NPAT shall include only the results of the Target and its subsidiaries as at the Closing Date, and shall exclude the results of any business, asset or entity contributed to or acquired by the Target or any of its subsidiaries after the Closing Date, unless the Company has agreed in writing that such results be included.
Currency. Performance NPAT shall be measured in RMB. Amounts recorded in any other currency shall be translated into RMB at the arithmetic average of the daily central parity rates of RMB against such currency published by the China Foreign Exchange Trade System during the relevant Performance Year.
Exhibit B — Form of Convertible Promissory Note
THIS INSTRUMENT AND THE SECURITIES ISSUABLE ON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE, AND HAVE BEEN OR WILL BE ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO TRANSFER OF THIS NOTE OR CONVERSION HEREOF MAY BE EFFECTED WITHOUT AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.
CONVERTIBLE PROMISSORY NOTE
| US$[●] | [●], 2026 (“Issuance Date”) |
| Number: PMA_LC_2026-[●] |
FOR VALUE RECEIVED, PMA Graphene Technology Group Inc. (formerly known as Ming Shing Group Holdings Limited), an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Maker” or “Company”), hereby promises to pay to the order of [●], a [●] established under the laws of [●], in its capacity as Note Recipient under the Acquisition Agreement (as such term is defined in the Agreement) (“Holder”), at such place as Holder may from time to time direct, in lawful money of the United States of America, a principal sum of US$[●] (the “Note Principal Amount”) in accordance with the terms and provisions of this Convertible Promissory Note (this “Note”).
This Note is issued pursuant to the terms of that certain Convertible Note Purchase Agreement (the “Agreement”), dated as of the date hereof, by and among the Company, Holder and the holder of the other Note issued pursuant to the Agreement, in connection with that certain Stock Purchase Agreement dated as of November 18, 2026 (the “Acquisition Agreement”) by and among the Company, the Holder, the other seller party thereto and Lanchuang Technology Limited. Capitalized terms used but not defined herein have the meanings given to them in the Agreement.
This Note may be redeemed or converted in accordance with the terms of this Note and the Agreement. This Note is a direct, unconditional, unsecured and unsubordinated obligation of the Company and ranks pari passu with all present and future unsecured and unsubordinated obligations of the Company, save for such obligations as may be preferred by mandatory applicable law.
SECTION 1
PRINCIPAL AND INTEREST
| A. | Principal. The outstanding principal balance of this Note at any one time is the Note Principal Amount less any principal amount converted pursuant to Section 4, redeemed pursuant to Section 2 or otherwise cancelled in accordance with the terms of this Note. The Note Principal Amount constitutes a valid and binding obligation of Maker in accordance with the terms and conditions contained herein. The Note Principal Amount constitutes acquisition consideration pursuant to the terms of the Acquisition Agreement, and no cash will be advanced by the Holder to the Maker pursuant to the terms of this Note. |
| B. | Interest. No ordinary interest shall accrue on the Note Principal Amount, and no interest payments shall be due on this Note. |
SECTION 2
GENERAL TERMS
| A. | Maturity Date. This Note has no fixed maturity date and shall remain outstanding unless and until converted in full, redeemed pursuant to an express provision herein, repurchased by the Maker and cancelled, or otherwise cancelled by written agreement of the Maker and the Holder in accordance with the terms of this Note. |
| B. | No Prepayment. Except as otherwise indicated in this Note, the balance of the Note Principal Amount of this Note may not be prepaid by Maker, in whole or in part. |
| C. | Payments. All payments hereunder shall be made in lawful money of the United States of America at such place as Holder may direct, by check payable to Holder or by wire transfer to a bank designated by Holder. All payments made by Maker under this Note shall be applied to the outstanding balance of the Note Principal Amount of the Note. |
| D. | No Scheduled Redemption; No Amortization; No Repurchase. This Note shall not be subject to any scheduled amortization, sinking fund or mandatory redemption by reason only of the passage of time. The Maker shall have no obligation to repay the Note Principal Amount on any fixed date. The Maker may not redeem, repurchase or otherwise retire this Note, in whole or in part, without the prior written consent of the Holder, except to the extent required by applicable law or necessary by reason of tax, illegality, regulatory prohibition or a similar mandatory legal reason, in which case such redemption or repurchase shall be effected at a price equal to 100% of the outstanding Note Principal Amount so redeemed or repurchased, upon prior written notice to the Holder. Any portion of the Note so redeemed or repurchased by the Maker shall forthwith be cancelled and may not be reissued. |
| E. | Holder Put Right Upon Fundamental Change. Upon the occurrence of a Fundamental Change, the Maker shall give the Holder prompt written notice thereof, and the Holder shall have the right, exercisable by written notice delivered to the Maker within twenty (20) Business Days after receipt of such notice, to require the Maker to redeem all or any part of the outstanding Note Principal Amount under this Note designated by the Holder at 101% of the then outstanding Note Principal Amount to be redeemed. Such redemption shall be effected on a date designated by the Holder in its notice, which date shall be not less than five (5) Business Days nor more than twenty (20) Business Days after the Maker’s receipt of such notice. Any portion of this Note not so redeemed shall remain outstanding in accordance with its terms. “Fundamental Change” means: (a) the delisting of the Maker’s Class A Ordinary Shares from Nasdaq without listing on another Primary Market (as hereinafter defined); (b) any merger, amalgamation, consolidation, scheme of arrangement, sale of all or substantially all assets or similar transaction resulting in a change of control of the Maker; or (c) any liquidation, dissolution or winding up of the Maker. |
SECTION 3
EVENTS OF DEFAULT; RIGHTS AND REMEDIES
| A. | Events of Default. For purposes of this Note, “Event of Default” means any one or more of the following events, conditions or acts: |
| i. | Failure by the Maker to pay any amount when due under an express redemption obligation, repurchase obligation or other payment obligation arising under this Note or the Agreement; |
| ii. | Failure by the Maker to issue Conversion Shares when due in accordance with the terms of this Note and the Agreement, other than where such failure results solely from incomplete information or certification provided by the Holder or from a legal or regulatory impediment not arising from a breach by the Maker of the terms of this Note or the Agreement; |
| iii. | The Company shall fail to observe or perform any material covenant or obligation contained in, or otherwise commit any material breach of, this Note or the Agreement, and such failure or breach (if capable of remedy) is not remedied within thirty (30) days after written notice from the Holder; |
| iv. | The Maker (a) files, or consents by answer or otherwise to the filing against it of, a petition for relief or reorganization or arrangement or any other petition in bankruptcy, for liquidation or to take advantage of any bankruptcy, insolvency, reorganization, moratorium or other similar law of any jurisdiction, (b) makes an assignment for the benefit of its creditors outside the ordinary course of business, (c) consents to the appointment of a custodian, receiver, trustee or other officer with similar powers with respect to it or with respect to any substantial part of its property, (d) is adjudicated as insolvent or to be liquidated or is otherwise liquidated or dissolved, or (e) takes corporate action for the purpose of any of the foregoing; |
| v. | Any material provision of this Note, at any time after its execution and delivery and for any reason other than as expressly permitted hereunder, ceases to be in full force and effect or this Note ceases to be a binding obligation of the Maker; or |
| vi. | The Class A Ordinary Shares shall cease to be quoted or listed for trading, as applicable, on any Primary Market for a period of 30 consecutive Business Days. “Primary Market” means any of The New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market or the Nasdaq Global Select Market, and any successor to any of the foregoing. |
| B. | Rights and Remedies. Upon the occurrence of any Event of Default which is continuing (and, in the case of an Event of Default under clause (iii), which remains uncured following the applicable cure period), the Holder may by written notice to the Maker declare immediately due and payable any amounts then due and payable under this Note and the Agreement and may pursue specific performance, injunctive relief and any other remedy available at law or in equity with respect to obligations expressly payable or performable thereunder; provided that, for the avoidance of doubt, acceleration shall not create a fixed maturity date for any portion of this Note that is not otherwise due and payable under the terms of this Note or the Agreement, except to the extent otherwise expressly provided therein. |
| C. | Waivers. No waiver under this Section 3 by Holder shall be deemed to have been made unless such waiver is in writing and signed by Holder or confirmed to Maker by electronic communication by an authorized party of Holder. Holder reserves the right to waive or refrain from waiving any right or remedy under this Note. No delay or omission on the part of Holder in exercising any right or remedy under this Note shall operate as a waiver of such right or remedy or of any other right or remedy under this Note. A waiver on any one occasion shall not be construed as a bar to or waiver of any such right or remedy on any future occasion. |
SECTION 4
CONVERSION
| A. | Conversion Right. Subject to the limitations of Section 4.C and Section 4.D, at any time or times on or after the applicable Conversion Eligibility Date, and for so long as the relevant Annual Performance Tranche remains eligible for conversion in accordance with the terms of this Note, the Holder shall be entitled to convert all or any portion of the outstanding and unpaid Note Principal Amount of such Annual Performance Tranche (the “Conversion Amount”) into fully paid and nonassessable Class A Ordinary Shares in accordance with Section 4.B, at a price of $1.30 per Class A Ordinary Share, being a fixed price agreed by the parties and inserted in this Note and not subject to any floating formula, market-price reset, ratchet, repricing or similar variable-price feature, except for customary structural adjustments expressly set forth herein (the “Conversion Price”). The number of Class A Ordinary Shares issuable upon conversion of any Conversion Amount pursuant to this Section 4.A shall be determined by dividing (x) such Conversion Amount by (y) the Conversion Price. The Company shall not issue any fraction of a share of Class A Ordinary Shares upon any conversion. If the issuance would result in the issuance of a fraction of a share of Class A Ordinary Shares, the Company shall round such fraction of a share of Class A Ordinary Shares down to the nearest whole share. The Company shall pay any and all transfer, stamp and similar taxes that may be payable with respect to the issuance and delivery of Class A Ordinary Shares upon conversion of any Conversion Amount. For the avoidance of doubt, the Holder shall bear taxes arising from its ownership, transfer or disposition of the Note or Conversion Shares, except to the extent otherwise required by law. Any residual principal amount resulting solely from such rounding down shall remain outstanding under this Note and shall continue to be convertible in accordance with its terms. |
| B. | Mechanics of Conversion. |
| i. | To convert any Conversion Amount into Class A Ordinary Shares on any date (a “Conversion Date”), the Holder, following receipt of a Conversion Eligibility Notice in respect of the applicable Annual Performance Tranche, shall (A) transmit by email (or otherwise deliver), for receipt on or prior to 11:59 p.m., New York Time, on such date, a copy of an executed notice of conversion in the form attached hereto as Exhibit I (the “Conversion Notice”) to the Company, together with a certification of its then current beneficial ownership position and such supporting information as the Company may reasonably require to confirm compliance with Section 4.C, and (B) if required by Section 4.B.ii, surrender this Note to a nationally recognized overnight delivery service for delivery to the Company (or an indemnification undertaking reasonably satisfactory to the Company with respect to this Note in the case of its loss, theft or destruction). On or before the third (3rd) Business Day following the date of receipt of a valid Conversion Notice and such certification (the “Share Delivery Date”), the Company shall (X) if legends are not required to be placed on certificates of Class A Ordinary Shares and provided that the Transfer Agent is participating in the Depository Trust Company’s (“DTC”) Fast Automated Securities Transfer Program, credit such aggregate number of Class A Ordinary Shares to which the Holder shall be entitled to the Holder’s or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system or (Y) if the Transfer Agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver to the address as specified in the Conversion Notice, a certificate, registered in the name of the Holder or its designee, for the number of Class A Ordinary Shares to which the Holder shall be entitled which certificates shall not bear any restrictive legends unless required pursuant to rules and regulations of the SEC. If this Note is physically surrendered for conversion and the outstanding Note Principal Amount of this Note is greater than the portion of the Conversion Amount being converted, then the Company shall as soon as practicable and in no event later than three (3) Business Days after receipt of this Note and at its own expense, issue and deliver to the holder a new Note representing the outstanding Principal not converted. The Holder shall be treated as the record holder only upon the valid issuance or crediting of the applicable Class A Ordinary Shares in accordance with this Note and applicable law. |
| ii. | Notwithstanding anything to the contrary set forth herein, upon conversion of any portion of this Note in accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Company unless (A) the full Conversion Amount represented by this Note is being converted or (B) the Holder has provided the Company with prior written notice (which notice may be included in a Conversion Notice) requesting reissuance of this Note upon physical surrender of this Note. The Holder and the Company shall maintain records showing the Note Principal Amount converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Company, so as not to require physical surrender of this Note upon conversion. |
| C. | Beneficial Ownership Limitation. Notwithstanding anything to the contrary contained in this Note or the Agreement, the Company shall not effect any conversion of this Note, and the Holder shall not have the right to convert any portion of this Note, to the extent that immediately after giving effect to such conversion the Holder, together with its affiliates, its beneficial owner(s) and any other Persons whose beneficial ownership would be aggregated with the Holder under Section 13(d) of the Exchange Act, would directly or indirectly beneficially own more than 9.99% of the then issued and outstanding Class A Ordinary Shares (the “Beneficial Ownership Limitation”). The Beneficial Ownership Limitation shall apply at all times during the life of this Note, shall be a continuing condition to each conversion, and shall apply to all Class A Ordinary Shares beneficially owned by such Persons, including the Consideration Shares and Conversion Shares previously issued. If any requested conversion would cause a breach of the Beneficial Ownership Limitation, such conversion shall automatically be reduced to the maximum principal amount that may be converted without such breach, and any principal tendered in excess thereof shall remain outstanding and continue to be convertible in accordance with this Note, subject to Section 4.D. The Beneficial Ownership Limitation shall not be increased above 9.99% unless expressly agreed by the Company and the Holder and only to the extent legally permissible under applicable securities laws, Nasdaq rules and the Company’s corporate approvals. The Holder represents and warrants that it has disclosed all affiliates, ultimate beneficial owners and other Persons whose beneficial ownership must be aggregated with the Holder for purposes of this Section 4.C. |
| D. | Performance Tranche Limitation and Conversion Eligibility. |
| i. | For purposes of determining conversion eligibility under Section 4.A, the Note Principal Amount of this Note shall be divided into three annual performance tranches of $[●], $[●] and $[●], respectively (each, an “Annual Performance Tranche” and collectively, the “Annual Performance Tranches”) in the amounts and proportions set forth on Annex I to the Agreement. The Annual Performance Tranches shall correspond respectively to the three financial periods specified in the Performance Schedule attached as Schedule 1 to the Agreement (the “Performance Schedule”). Each such financial period is referred to herein as a “Performance Year,” and collectively, the “Performance Years.” |
| ii. | The Principal amount under this Note corresponding to each Annual Performance Tranche shall be eligible for conversion only after completion of such Performance Year and only if the Target achieves the performance target specified for such Performance Year in the Performance Schedule (the “Performance Target”). Each Annual Performance Tranche shall be assessed separately and solely by reference to the corresponding Performance Year. Only the metrics and thresholds expressly agreed in the Performance Schedule shall be used to determine conversion eligibility unless expressly agreed by the Company in writing; |
| iii. | Within sixty (60) days after the end of the relevant Performance Year, the Company, acting reasonably and in good faith, shall determine, on the basis of the financial information of the Target and its subsidiaries available to the Company as their parent company (including management accounts and consolidation records), whether the applicable Performance Target has been satisfied. No audit of the financial statements of the Target for any Performance Year shall be required for the purposes of such determination. The Company’s determination shall be final and binding on the Holder absent manifest error. If the Company determines that the applicable Performance Target has been satisfied, the Company shall promptly notify the Holder in writing of such determination (a “Conversion Eligibility Notice”), and the relevant Annual Performance Tranche shall become eligible for conversion on the date of such notice (the “Conversion Eligibility Date”). No Annual Performance Tranche may be converted unless and until the Company has delivered a Conversion Eligibility Notice in respect of such Annual Performance Tranche. Once an Annual Performance Tranche becomes eligible for conversion, it shall remain eligible for conversion until converted, redeemed, repurchased or otherwise cancelled in accordance with the terms of this Note; and |
| iv. | If it is not determined pursuant to Section 4.D(iii) that the applicable Performance Target has been satisfied, the relevant Annual Performance Tranche shall remain outstanding but shall not be convertible unless otherwise expressly agreed by the Company in writing. For the avoidance of doubt, the satisfaction of the Performance Target for any subsequent Performance Year shall not render convertible any Annual Performance Tranche relating to a prior Performance Year that failed to satisfy the applicable Performance Target. |
| E. | Other Provisions. |
| i. | All calculations under this Section 4 shall be rounded to the nearest $0.0001 or, in the case of any number of Class A Ordinary Shares, down to the nearest whole share in accordance with Section 4.A. |
| ii. | The Company shall at all times while this Note remains outstanding reserve and keep available out of its duly authorized and unissued Class A Ordinary Shares, free of preemptive rights, a sufficient number of Class A Ordinary Shares to satisfy conversion of the full outstanding Note Principal Amount of this Note at the Conversion Price and other notes issued pursuant to the Agreement, subject always to the Beneficial Ownership Limitation, Performance Tranche Limitation and applicable law (the “Required Reserve Amount”), and shall instruct its transfer agent to maintain such reservation. If at any time the number of Class A Ordinary Shares authorized but unissued and not otherwise reserved for issuance is not sufficient to meet the Required Reserve Amount, the Company shall use its commercially reasonable efforts to seek shareholder approval to increase its authorized share capital as promptly as practicable, in compliance with Cayman Islands law, the M&A and the Nasdaq Rules. The Company shall also make all Nasdaq notifications, supplemental listing applications and other filings required in connection with this Note and any issuance of Class A Ordinary Shares upon conversion. The Company covenants that, upon issuance in accordance with this Note, the Class A Ordinary Shares will be validly issued, fully paid and nonassessable. |
| iii. | The Company shall cause its legal counsel to deliver legal opinions to the Company’s transfer agent in connection with any legend removal upon the expiration of any holding period or other requirement for which the Class A Ordinary Shares may bear legends restricting the transfer thereof. |
| iv. | The Holder represents and warrants that the Financial Forecast, including the forecast performance for each Performance Year, has been prepared in good faith based on assumptions believed by the Target and the Holder to be reasonable at the time of preparation, and that all material assumptions, limitations and dependencies relevant to the Financial Forecast have been fairly disclosed to the Company. |
| v. | For so long as any Annual Performance Tranche remains outstanding and non-convertible, the Holder shall, to the extent it has the legal right or practical ability to do so, use its best efforts to cause the Target to provide the Company with financial statements, management accounts, supporting schedules, tax computations and other information reasonably required by the Company to determine the actual performance of the Target for the relevant Performance Year and whether the Performance Target has been satisfied in accordance with Section 4.D. |
| vi. | If the Company, at any time while this Note is outstanding, shall (a) pay a stock dividend or otherwise make a distribution or distributions on shares of its Class A Ordinary Shares or any other equity or equity equivalent securities payable in Class A Ordinary Shares, (b) subdivide outstanding Class A Ordinary Shares into a larger number of shares, (c) combine (including by way of reverse stock split) outstanding Class A Ordinary Shares into a smaller number of shares, or (d) issue by reclassification of Class A Ordinary Shares any shares of capital stock of the Company, then the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of Class A Ordinary Shares (excluding treasury shares, if any) outstanding before such event and of which the denominator shall be the number of Class A Ordinary Shares outstanding after such event. Any adjustment made pursuant to this Section shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or reclassification. |
| F. | Nasdaq and Home Country Practice. Notwithstanding anything to the contrary herein, the Company shall not be required to issue, and the Holder shall not be entitled to receive, any Class A Ordinary Shares upon conversion of this Note to the extent that such conversion would require shareholder approval under Nasdaq Rule 5635, unless and until such approval has been obtained or the Company has confirmed, on the advice of counsel and following consultation with Nasdaq, that an exemption is available. The Company shall be responsible for making all filings, disclosures, submissions, notifications and other procedural steps required in connection with any such reliance. The Company represents and warrants that, as of the date of the issuance of this Note, the Company is eligible for an exemption from such shareholder approval requirements in accordance with the Company’s disclosed home country practices under Nasdaq Listing Rule 5615(a)(3). If, after the Issuance Date, the Company ceases to be entitled to rely on such position in a manner that materially affects the conversion mechanics contemplated hereby, the parties shall cooperate in good faith to amend the conversion mechanics or provide for redemption, repurchase or other lawful settlement of the affected portion of this Note so as to preserve the commercial intent of this Note to the maximum extent legally permissible. |
SECTION 5
MISCELLANEOUS
| A. | Transfers and Reissuance. The Note may not be transferred, assigned or otherwise disposed of by the Holder without the prior written consent of the Maker, save that transfers to an affiliate of the Holder may be permitted subject to prior written notice to the Maker, compliance with applicable securities laws, execution of a deed of adherence or equivalent undertaking, and the continued application of the Beneficial Ownership Limitation, and Performance Tranche Limitation to such transferee. The Note and any Class A Ordinary Shares issued upon conversion hereof shall be subject to customary securities law transfer restrictions, restrictive legends and stop-transfer instructions until transfer is permitted under applicable law and this Note. If this Note is to be transferred, the Holder shall surrender this Note to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Note, registered in the name of the registered transferee or assignee, representing the outstanding Note Principal Amount being transferred by the Holder and, if less than the entire outstanding Note Principal Amount is being transferred, a new Note to the Holder representing the outstanding Principal not being transferred. The Holder and any assignee, by acceptance of this Note, acknowledge and agree that following conversion or redemption of any portion of this Note, the outstanding Principal represented by this Note may be less than the Note Principal Amount stated on the face of this Note. |
| B. | Lost, Stolen or Mutilated Note. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Note, the Company shall execute and deliver to the Holder a new Note representing the outstanding Note Principal Amount. |
| C. | Amendments. Any term of this Note may be amended, modified or waived only with the written consent of the Company and the Holder, or, where the amendment, modification or waiver affects all Holders or the overall structure of the transaction, the Company and all Holders, in accordance with the amendment provisions of the Agreement. |
| D. | Severability. If any term, covenant or provision contained in this Note, or its application to any Person or circumstance, is determined to be void, invalid, illegal or unenforceable to any extent, such term, covenant or provision only shall be deemed not contained in this Note, and the remainder of this Note shall remain in full force and effect and be enforced to the greatest extent permitted by law. |
| E. | Captions. The captions or headings at the beginning of any paragraph or portion of any paragraph in this Note are for the convenience of Maker and Holder and for purpose of reference only and shall not limit or otherwise alter the meaning of the provisions of this Note. |
| F. | Governing Law; Venue. The construction and enforcement of this Note shall be governed by the internal laws of the State of New York, without regard to choice of law principles that would result in the application of the law of another jurisdiction. The state courts of the State of New York located in Manhattan, New York County, and the United States District Court for the Southern District of New York shall have exclusive jurisdiction to hear and determine any dispute arising out of or in connection with this Note and the related definitive documents, and each party irrevocably submits to such jurisdiction. THE PARTIES TO THIS NOTE HEREBY WAIVE THEIR RIGHT TO A TRIAL BY JURY WITH RESPECT TO DISPUTES ARISING UNDER THIS NOTE AND THE RELATED AGREEMENTS AND CONSENT TO A BENCH TRIAL WITH THE APPROPRIATE JUDGE ACTING AS THE FINDER OF FACT. |
| G. | Notices. Any notice, request or other communication required or permitted hereunder shall be in writing and shall be given, and deemed duly given, in the manner set forth in Section 7.8 of the Agreement, to the relevant party at the address or email set forth below (or such other address or email as such party may designate by notice given in accordance with Section 7.8 of the Agreement): |
If to Maker:
Address: Office Unit B8, 27/F, NCB Innovation Centre, No. 888 Lai Chi Kok Road, Cheung Sha Wan, Kowloon, Hong Kong;
Contact: Chi Ming Lam; Email: ir@ms100.com.hk
If to Holder: Address: [●]; Contact: [●]; Email: [●]
| H. | Binding Effect; Successors and Assigns. This Note and the rights and obligations hereunder shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns. |
| I. | Withholding. The Company shall be entitled to make any withholding required by law, provided that it gives reasonable prior notice to the Holder and cooperates in good faith to minimize such withholding where legally permissible. |
** **
| J. | Securities Law Compliance. Holder has been advised that the Note and the underlying securities have not been registered under the Securities Act, or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an exemption from such registration requirements is available. Holder is aware that Maker is under no obligation to effect any such registration with respect to the Note or the underlying securities or to file for or comply with any exemption from registration. Holder is purchasing the Note to be acquired by Holder hereunder for its own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and Holder has no present intention of selling, granting any participation in, or otherwise distributing the same. Holder has such knowledge and experience in financial and business matters that Holder is capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment without impairing Holder’s financial condition and is able to bear the economic risk of such investment for an indefinite period of time. Holder further represents and warrants as follows: |
** **
| i. | Holder and all owners, members, partners or any individual or entity having an equity interest in Holder are not “U.S. Persons” within the meaning of Regulation S under the Securities Act. Holder is acquiring this Note and any Conversion Shares for its own account, for investment and not for distribution or resale to others, and not for the account or benefit of any “U.S. Person.” |
** **
| ii. | Holder has not paid, and will not pay, any commission or other remuneration to any person as a commission or fee for this Note. |
** **
| iii. | Holder has been afforded access to all material books, records and contracts of Maker and has had an opportunity to ask questions of and receive answers from Maker concerning the terms and conditions of this investment, and all such questions have been answered to its full satisfaction. |
** **
| iv. | Holder has had the opportunity to consult with legal counsel in making the representations above and otherwise in regard to this Note. |
** **
[Signature Page Follows]
** **
IN WITNESS WHEREOF, Maker has caused this Convertible Promissory Note to be duly executed as of the Issuance Date.
| MAKER: PMA GRAPHENE TECHNOLOGY GROUP INC. | ACKNOWLEDGED AND AGREED — HOLDER: [●] | |||
| By: | By: | |||
| Name: | LIU Lei | Name: | ||
| Title: | Chief Executive Officer | Title: | ||
| Date: | Date: |
Exhibit I — Conversion Notice
Reference is made to Convertible Promissory Note No. PMA_LC_2026-[●] (the “Note”) issued by PMA Graphene Technology Group Inc. (the “Company”). The undersigned Holder hereby elects to convert the Conversion Amount specified below of the Annual Performance Tranche for Performance Year [1/2/3] (Conversion Eligibility Date: [●]) into Class A Ordinary Shares at the Conversion Price of US$1.30, as of the date specified below, subject to the Beneficial Ownership Limitation and the Performance Tranche Limitation.
| Date of Conversion | [●] | |
| Conversion Amount | US$[●] | |
| Number of Class A Ordinary Shares (rounded down) | [●] | |
| Please issue the Class A Ordinary Shares in the following name and to the following DTC / transfer agent account | [●] | |
| Request reissuance of Note for unconverted principal | [Yes / No] |
Beneficial Ownership Certification. The Holder certifies that (a) as of the date hereof, the Holder, together with its affiliates, its beneficial owner(s) and all Persons whose beneficial ownership would be aggregated with it under Section 13(d) of the Exchange Act, beneficially owns [●] Class A Ordinary Shares (including Consideration Shares and previously issued Conversion Shares), representing [●]% of the issued and outstanding Class A Ordinary Shares; (b) after giving effect to this conversion, such Persons would beneficially own [●]%, which does not exceed 9.99%; (c) its ultimate beneficial owner(s) are: [●]; and (d) the Persons aggregated with it are: [●].
| HOLDER: [●] | ||
| By: | ||
| Name: | [●] | |
| Title: | [●] | |
| Date: |